@prefix ns1: <http://www.w3.org/ns/prov#> .
@prefix ns2: <https://schema.org/> .
@prefix ns3: <https://w3id.org/neurodkg/> .

<http://purl.bioontology.org/ontology/MEDDRA/10001543> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA1a_8AKy1hdB1myNdczSEYJ_nYQ6Vt4zp6z6KKvbvFCI#medtherapy>,
        <http://purl.org/np/RAr35wxXundGgR2ycR3eZnPmloYOQ1Ip3a6A3pgZbqiQ0#medtherapy> .

<http://purl.bioontology.org/ontology/MEDDRA/10003620> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAVnbvtQSRA3gN-YCc5RDoJfwRU8yUvr_3ll0f3TQODf0#medtherapy> .

<http://purl.bioontology.org/ontology/MEDDRA/10021750> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#medtherapy> .

<http://purl.bioontology.org/ontology/MEDDRA/10028333> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA_yy84QQBDGT7sMF22SuryjW56nraTqqmJB_Whhiql4Y#medtherapy> .

<http://purl.bioontology.org/ontology/MEDDRA/10028334> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA9vXvECxARQAwEJ3GZEevkv225IOuaobDjGoXt4jUOH8#medtherapy>,
        <http://purl.org/np/RADpzcvCoFfLrH_m6PIbEyrpTBI0TDVgbzTaIBgKortag#medtherapy>,
        <http://purl.org/np/RAYvT2opGh-4_7tLm8LPGT-hEbPPo14_agjHaYcZee66c#medtherapy> .

<http://purl.bioontology.org/ontology/MEDDRA/10041242> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAyveo6zcLmZSFEGoyAeMma-904_aPF_v143JhtP_SC7s#medtherapy> .

<http://purl.bioontology.org/ontology/MEDDRA/10061334> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RANL2PUfRN6-Ps9oO3AVs2NuyWjccP8yPINMnwRbCtUzY#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_0050214> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA0Ki-qBZ2Kc2fX9zdtmbQYuqC0SjB2PkhHxawjA_B1TA#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_0050425> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAi6IZmGwMCIuMxSab0NUW4bfWtR3m91HewclLVWxXxSA#medtherapy>,
        <http://purl.org/np/RAwa1r-Auffn2MDHyFUfKBQKuiSqZK5S65IFdeLtDql1s#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_0050741> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA9HbDSDxk8nMofWUuSzBgf4DXrb195jxJomi6wtYdG18#medtherapy>,
        <http://purl.org/np/RASX99d9pr79inB-QYzelBosH3vJq3yXmCNTM2CWdeCB4#medtherapy>,
        <http://purl.org/np/RA_pMhpmS3t3JwsrNixJvQZtEq0YOIKgIstTcgmw30Cuk#medtherapy>,
        <http://purl.org/np/RAo1cJZBUOs9LhgAsqvTZWt02EL-mHxiYpEJaunijpQIA#medtherapy>,
        <http://purl.org/np/RApYLfwfyTJ7lKQuesHrBh80zpkKyWpCrDc_plCVEwLW0#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_0060167> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAP12f5lS-xIlOhUN_1TfUXr_rD6zV0yaIL5WA6OVZsVw#medtherapy>,
        <http://purl.org/np/RAdA4fRU2LJMyBlcrde2uTxo7Xwoi23SAHXbRLboIvZTk#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_10652> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA6j9ngf7h2h_jWjqkJdM_RcToQpooMUEHVd1BWzIH5ys#medtherapy>,
        <http://purl.org/np/RAv-n0KEBxf2JyY8cDdAfhtDBwjtP8Np9b-yn-BHZl0Qg#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_10933> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA6YjOCgmeoLeClhT2jjHtKulbRyBJPPLYA9HyvbNcsPw#medtherapy>,
        <http://purl.org/np/RATi0q3mcdhzdBIPpLDVsHBiPDH7NjqJC8g1-PDBc6sUQ#medtherapy>,
        <http://purl.org/np/RA_0ay3tAx_-uDcvwHRRkPxR78Ezvs-1sw5a3lluXUCxA#medtherapy>,
        <http://purl.org/np/RAolwAqvqw_3V9EK_PSwyawD0eXPfkJ8XJOAHLkZmzDmM#medtherapy>,
        <http://purl.org/np/RAvxGuz3o7uA48O-l5wUUrm_CEuuO9uG_YF3vI6O0918o#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_1094> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA4wuBZAwMlQapNzm2ER6CdJP__bCKkD9yN_J3Ht0DH80#medtherapy>,
        <http://purl.org/np/RAMBLDIneLdqSDF5Ppb0vKyqYKs2ecJHgvwZcpOBq7n88#medtherapy>,
        <http://purl.org/np/RARZxdx5w8R_LaJHHGxT64nvFHVwrQdHnn4CH07QBEZmI#medtherapy>,
        <http://purl.org/np/RAUUK3nf5YbAO_uPlkOliVDJo3m-JnTMxa7qu9TWZQZ18#medtherapy>,
        <http://purl.org/np/RAaTX5aHox7tzzPG9AMdX1SYvVVLT0O0UMTXQNgpHaWyA#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_11119> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RARIsITXB4P5uL2XBy6jxw8M-KSWCuPsYpe8fXXiV4Sd8#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_11257> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAPtJoTJ2wBfxa0KCSi-uvOtJN5GpjFOBDDWJmUmSZ16U#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_11338> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAjHiPctclLo02Y_fYTyDkpUinnxmFOfTqlEsgpfuMvCE#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_12859> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAeknHMktChyEjUGeoJko4GkBrrfX4ZjLDOSYXpVHUcX8#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_12894> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA3TnVWbjO2l5MATOgoyN_4nZDAqWn4iIiTUrestt0iNs#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_13366> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA2tgUbYrtdDIcmFOCcHBxnXXrFJRsvUfLMvBDnXyW1kY#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_14320> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAGqE-5Za5IIEDuOvf5-9jdhn2B9f2dfCgp4zhTSYw_1w#medtherapy>,
        <http://purl.org/np/RALa6tOiCWAvRoo_pwjRkAY8w5hwxp5ZCUuqAZzWh0N5g#medtherapy>,
        <http://purl.org/np/RAcRBXfdJ72S0buCh-nka-5L3GgJbA5lHbwbbvc1yhPcw#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_14330> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA0_ZsJUyGmKDHUMgctrXgCR9dGyS_iCMTdz6TQhj0P_o#medtherapy>,
        <http://purl.org/np/RA7ZXjeMdR-Oj8cSGBHc1QT3bybQL8lvNNcnJEfqWfaSA#medtherapy>,
        <http://purl.org/np/RA93ZLqk55xHV2AgL_HqnQabkJwAdiN9UgtAV_Mw-GgDs#medtherapy>,
        <http://purl.org/np/RAGWb7x_-l63jDaRH1e6Edf3hImTqvB_dOYXWNq3AbDgE#medtherapy>,
        <http://purl.org/np/RAdQtrGuinuXuvRna6BEKb_V9aL81mrPIji-SgcIxiUF0#medtherapy>,
        <http://purl.org/np/RAjjpJ8F8ak6gw_7kD3ST1jgH2Dh9U34RplBA9J6tNP3o#medtherapy>,
        <http://purl.org/np/RAmhgfMT81pvxE-TD0vTNffPUmnheLfc5_MzUOHz582cI#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_1470> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA8vJY1e5gl8Te-Qver4whvJa9OHvBp2lRHH6DdPBUeNU#medtherapy>,
        <http://purl.org/np/RABhtK76h7GF2p3ZqFYRVL_si6QSJF9b2syqKHwJC2scE#medtherapy>,
        <http://purl.org/np/RADAM9VAVOWerQuwFfwMyD-gDOteafAwQYwW4JgHsQJN4#medtherapy>,
        <http://purl.org/np/RADxMF96mfnO8Lkpdn3dsherznOvalMYi4COH8IeGyqNE#medtherapy>,
        <http://purl.org/np/RANP4fACL3Mm4Kg4Bj8ykf-WWSl8czJV2I_gqnFP6txbQ#medtherapy>,
        <http://purl.org/np/RAP-jD7XFEwMmtVSvvn286ZkMh_SkQ5NTeH5GCeRESMII#medtherapy>,
        <http://purl.org/np/RAS__Y0u2wSFDLM4FcTwWhBg5EOe-3aqclkPEgmWSH4jA#medtherapy>,
        <http://purl.org/np/RAZ31mwyrGNeOAlzXZWCkfxmUXwwMUqRDkiBrdwFqABRw#medtherapy>,
        <http://purl.org/np/RAZM3lGBHEj1hzRcGBNp7FhB7FBKk7crUEyUTTCDv5fBo#medtherapy>,
        <http://purl.org/np/RAfWKLJ_YtuQUAiulnJtEiVDqaMsL1OCxIDcsqfBLqlf0#medtherapy>,
        <http://purl.org/np/RAiFVJiWLwjb9S5XpQ3hw9HSX5sj5Ggn4VYN1RkxGBFa0#medtherapy>,
        <http://purl.org/np/RAlOsJ35aCx0B-TZrbf0ldAI6pUXWdUiIuP3JjoZbO9bY#medtherapy>,
        <http://purl.org/np/RAnPHasurBSXkBHn9Kwm6aDJyrgkekc5927fVTTzHZbe4#medtherapy>,
        <http://purl.org/np/RAq0pljKvE6O_AGxGHkh1SONBPo2AhQj4r40Qyi7nj3CA#medtherapy>,
        <http://purl.org/np/RAq8zqvCqJSbrKJQ0_Lf75mRWyXzlHipV5vbSe6-cHZ_g#medtherapy>,
        <http://purl.org/np/RAvJsGhV9iHDO9ROYo6u505WGpdFdhf9KN_D0Y615QLFA#medtherapy>,
        <http://purl.org/np/RAy8bkI3AcqM8QmbzD6cliOUcQdGruCIpPKak4v9NdVx0#medtherapy>,
        <http://purl.org/np/RAyDzLntiVLeZa2RNoi55Ow6ojE8RDb_3ngKDimXFicr8#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_1595> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAJoCWIddRpNJwjYWs4ADKWFVqesZUDkYhZQq1d4Q5DsM#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_1596> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA0kL1vIx5GkzRRerK8loobEldBtbzc1QQU-4RovzYqBw#medtherapy>,
        <http://purl.org/np/RA7uwFdY5LZlJRTAEgfdqOic3d7fCyivtmJfmSPNMLvDE#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_1824> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAD8RAc3Apj670ag8pPgYT4x-ALud7gy_4Pfkv2ntj3I8#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_2030> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA4koEJfDMV1MAAlmLJb4gOPQERvwMAgi4DtfWxBwW-io#medtherapy>,
        <http://purl.org/np/RAcpGnsTznjYKeF2ESL6VwTAZuTmf3pdbDcl3Sf9l_SMo#medtherapy>,
        <http://purl.org/np/RAy8JkAfLP8_aPC6Wcc88bXlgrtQVStjUCFNXfivcwadI#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_2055> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RABS0ugQRHw6nqKlTste8ONPF8P3T9lUSA8alAK0aZIU0#medtherapy>,
        <http://purl.org/np/RAl4WREWS2kLIELieLL6y_fp0D7ZVwH-m2oSb-LzdhQnc#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_2377> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA0FfUtTu52nrMkVeP15MAQco8cycJJQJBU-jUfStW-rM#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_2559> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAMZo-qIoOhYneUeyQ8OGTQTeDwQTskjj0pSIw7S8ONKk#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_332> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAqc_p-BPO2VracLG3_X1LjJRHvWn1aXxHOFNfIfOwAkQ#medtherapy>,
        <http://purl.org/np/RAv3jvyRhHFwJRpDqoVUn5fgjWTJWcU26JmNFRvmpyMv0#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_437> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAjaVpcbWl5V3wThr9RfjXR-Y5nZMDVBsOF3oc_yN59Es#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_535> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAnLUKSpy5VDucMbVjgmMDX_H3Vtsu9qttypVQAZORHC4#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_5419> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA2UOITfDMkzWKcRckikJC6a_2-iErW8LZZ5cYDXfBmCQ#medtherapy>,
        <http://purl.org/np/RA2zKLyAuyeo6cHTfOknawUYaRg4M4pUeliAern9R_sJ8#medtherapy>,
        <http://purl.org/np/RAEq0Fo5IgBKowfdrbtsSqqhpGxzuAdvVB8s3W5uVryic#medtherapy>,
        <http://purl.org/np/RAIN0sRstQjV1KQlD36mmiibST08Ot_3Qlrmm6Ha7GGr8#medtherapy>,
        <http://purl.org/np/RAbUzIDUfwVgV6tveJX5PFTA9O7bDdO2cr8gfeXW8B_u4#medtherapy>,
        <http://purl.org/np/RAf8wCmRfuGxxSK0BhsSLxgEOrGWdk-lIcGBy7_MgU67g#medtherapy>,
        <http://purl.org/np/RAmiiMVoIdWEWsLw9fFuXPJlGsE6dRhc4X9LvjdY4FbPo#medtherapy>,
        <http://purl.org/np/RAtBB7ydnmSMrgPcr5hd2Z_rwQ8EzJz3pHWfNEsnJ04nQ#medtherapy>,
        <http://purl.org/np/RAvluTH6ahxoy0XuwfVTy3pGDitosYWrmTMinhzrRR1ro#medtherapy>,
        <http://purl.org/np/RAwn8YnBwDaBhsX6nZOMwLOtIwVnnPdX9hkUwRuZoe4-Q#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_594> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA8x6sYMM9dSQgjWIlzaFVZBhsanO4CPEQp1Szow4y32E#medtherapy>,
        <http://purl.org/np/RAAYpMR8lAxvV-aA4H_x7yABI_huscMEusKa1lc0AET_o#medtherapy>,
        <http://purl.org/np/RAJlzWs6I2Pzw-lHS6WCBBWIeymT_SOFhY5dvRa9zqfPM#medtherapy>,
        <http://purl.org/np/RAMvZYSyMNtfy1PH7IEAPNnp2eLsn63Hy-8_DBq0SDUgk#medtherapy>,
        <http://purl.org/np/RAOjFmtAh1s_ZkjDjf-7ZhHG2VPILfv_NjcEg1OoyWfsY#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_631> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA27UP6-CU0WWNQ_DYbv43lw1lBw_19egfMwBs4r4yyYA#medtherapy>,
        <http://purl.org/np/RA5zceJYEHlV2wTGXpWO9fMyCRP__HDYEwYxNYI83eUDg#medtherapy>,
        <http://purl.org/np/RA6nLgKKumV3t178HnkFMr_bsi_dnfbB3g3NEEgNakmTU#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_6364> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA_b4CBVFPDfQXNn4W-bKnkOLksphW_tWhaHxzwfEEww4#medtherapy>,
        <http://purl.org/np/RAo1dZTDE2eb359La5P9YIQiOo0TWZZM3eatB67_aOeYI#medtherapy>,
        <http://purl.org/np/RAsiYjA9w_3VpllRg01zPjz5ljxelgy2BAVYt_iBqXd1s#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_7725> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAPVRrJwOjMqct306AM_HYIxMOt37ldLa2OHwHtbTjdhE#medtherapy>,
        <http://purl.org/np/RASAH0yTnb2F3fYzixv9AxVI5MZPDSM9hLE55K0zOyXZI#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_8986> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAGyQL6v2QGO00ttIPrkeFIYwg2fgmfo5jTbws6jmWbes#medtherapy>,
        <http://purl.org/np/RAep04jBh9mzQ8bRaPGmD6QpjuP0iYVef6_S3cm35bc-s#medtherapy> .

<http://purl.obolibrary.org/obo/DOID_9743> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAppEliDizih-eOdMuanBbtpOVO5Mf7aZJVuvJvxi_5MM#medtherapy> .

<http://purl.obolibrary.org/obo/HP_0007359> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#medtherapy> .

<http://purl.obolibrary.org/obo/MONDO_0041052> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA7cGOVqnmN7UlaCf_WNPt8wIwxbEi4tbUttnQ6hb55ig#medtherapy> .

<http://purl.obolibrary.org/obo/MONDO_0043797> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAtsJmmAQaWwBE34o5qsvLBIUn38IgFgry4Ua7sW31a3k#medtherapy> .

<http://purl.obolibrary.org/obo/OAE_0002008> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA9EAQSYqhe0uJj1xN-XEVCuY1K-sFIB1KtI4gBA9GBdw#medtherapy> .

<http://purl.obolibrary.org/obo/SYMP_0000141> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA2Zis4uKzCdct67hojX4TfPY-SrgLlo-wF-Dvm044xwc#medtherapy> .

<http://purl.obolibrary.org/obo/SYMP_0000266> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAL6P8CIyE3RSB83OAqPrVo_808Fe87mXqLaG5IQeVqcg#medtherapy> .

<http://purl.obolibrary.org/obo/SYMP_0000271> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAZW8rLrF4eNXyUjFi5-p_RCY65f2Uq13458Nj2spZNgQ#medtherapy> .

<http://purl.obolibrary.org/obo/SYMP_0000272> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RACt5hvoATSAT196jCJRi4IZcPTOkx2mOmJn8HNNP161E#medtherapy>,
        <http://purl.org/np/RAhzeLbz6XHyBGj7cXxNgl-i47ongBoHptVGmth9x8Tb8#medtherapy> .

<http://purl.obolibrary.org/obo/SYMP_0000571> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA9_oHh9PXx4BzNI0D2uJ5GLqhzGFHnlwJhg2ILZY_Zh4#medtherapy>,
        <http://purl.org/np/RABbDk6fspKPxhoo9lIYlJNFKbRhurBS31Y7WLhMWMoVc#medtherapy>,
        <http://purl.org/np/RANFBhYZ_fPuI8_E0zWdSw35hu3sxsCMpWj2pV2dY1ntU#medtherapy>,
        <http://purl.org/np/RAl-2Jo0As-tdFyAexbYEfgnDPPq-PKxwvnRY6eoeGI5U#medtherapy> .

<http://purl.obolibrary.org/obo/SYMP_0000613> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAKSaOqvvlhH-AzyFzHhzYzINCheKAYF1NOm6vhpyC6FQ#medtherapy> .

<http://purl.obolibrary.org/obo/SYMP_0000832> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAnOfzebuEnpwFdcU40FF-Uwb1QpIyqoK6KwxXiW5-OsM#medtherapy> .

<http://purl.obolibrary.org/obo/SYMP_0000839> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RARyMK72tz-EMY27igrIvPbdvypnPR-SaDfb7ZIR1jFuA#medtherapy> .

<http://identifiers.org/drugbank/DB00185> a ns2:Drug .

<http://identifiers.org/drugbank/DB00193> a ns2:Drug .

<http://identifiers.org/drugbank/DB00215> a ns2:Drug .

<http://identifiers.org/drugbank/DB00285> a ns2:Drug .

<http://identifiers.org/drugbank/DB00289> a ns2:Drug .

<http://identifiers.org/drugbank/DB00313> a ns2:Drug .

<http://identifiers.org/drugbank/DB00363> a ns2:Drug .

<http://identifiers.org/drugbank/DB00370> a ns2:Drug .

<http://identifiers.org/drugbank/DB00371> a ns2:Drug .

<http://identifiers.org/drugbank/DB00395> a ns2:Drug .

<http://identifiers.org/drugbank/DB00402> a ns2:Drug .

<http://identifiers.org/drugbank/DB00404> a ns2:Drug .

<http://identifiers.org/drugbank/DB00422> a ns2:Drug .

<http://identifiers.org/drugbank/DB00423> a ns2:Drug .

<http://identifiers.org/drugbank/DB00425> a ns2:Drug .

<http://identifiers.org/drugbank/DB00458> a ns2:Drug .

<http://identifiers.org/drugbank/DB00482> a ns2:Drug .

<http://identifiers.org/drugbank/DB00490> a ns2:Drug .

<http://identifiers.org/drugbank/DB00494> a ns2:Drug .

<http://identifiers.org/drugbank/DB00545> a ns2:Drug .

<http://identifiers.org/drugbank/DB00586> a ns2:Drug .

<http://identifiers.org/drugbank/DB00623> a ns2:Drug .

<http://identifiers.org/drugbank/DB00656> a ns2:Drug .

<http://identifiers.org/drugbank/DB00669> a ns2:Drug .

<http://identifiers.org/drugbank/DB00697> a ns2:Drug .

<http://identifiers.org/drugbank/DB00704> a ns2:Drug .

<http://identifiers.org/drugbank/DB00740> a ns2:Drug .

<http://identifiers.org/drugbank/DB00776> a ns2:Drug .

<http://identifiers.org/drugbank/DB00788> a ns2:Drug .

<http://identifiers.org/drugbank/DB00843> a ns2:Drug .

<http://identifiers.org/drugbank/DB00850> a ns2:Drug .

<http://identifiers.org/drugbank/DB00921> a ns2:Drug .

<http://identifiers.org/drugbank/DB00924> a ns2:Drug .

<http://identifiers.org/drugbank/DB00945> a ns2:Drug .

<http://identifiers.org/drugbank/DB00956> a ns2:Drug .

<http://identifiers.org/drugbank/DB00980> a ns2:Drug .

<http://identifiers.org/drugbank/DB00998> a ns2:Drug .

<http://identifiers.org/drugbank/DB01043> a ns2:Drug .

<http://identifiers.org/drugbank/DB01050> a ns2:Drug .

<http://identifiers.org/drugbank/DB01086> a ns2:Drug .

<http://identifiers.org/drugbank/DB01100> a ns2:Drug .

<http://identifiers.org/drugbank/DB01247> a ns2:Drug .

<http://identifiers.org/drugbank/DB01255> a ns2:Drug .

<http://identifiers.org/drugbank/DB01589> a ns2:Drug .

<http://identifiers.org/drugbank/DB01623> a ns2:Drug .

<http://identifiers.org/drugbank/DB04844> a ns2:Drug .

<http://identifiers.org/drugbank/DB04896> a ns2:Drug .

<http://identifiers.org/drugbank/DB04946> a ns2:Drug .

<http://identifiers.org/drugbank/DB11632> a ns2:Drug .

<http://identifiers.org/drugbank/DB11640> a ns2:Drug .

<http://identifiers.org/drugbank/DB12243> a ns2:Drug .

<http://identifiers.org/drugbank/DB14509> a ns2:Drug .

<http://purl.bioontology.org/ontology/MEDDRA/10013082> a ns2:MedicalCondition .

<http://purl.bioontology.org/ontology/MEDDRA/10026778> a ns2:MedicalCondition .

<http://purl.bioontology.org/ontology/MEDDRA/10037214> a ns2:MedicalCondition .

<http://purl.bioontology.org/ontology/SNOMEDCT/48333001> a ns2:MedicalCondition .

<http://purl.obolibrary.org/obo/DOID_0111327> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAsvNtNLN-qHRjBcnHd5FuIbL-7I-2um_Sy_pc2ffLBxo#medtherapy> ;
    ns2:signOrSymptom <https://identifiers.org/MONDO:0020074> .

<http://purl.obolibrary.org/obo/DOID_12129> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA4NxwTQlS0Lyc3lrJ3qp73SKnXhmPWoNYqd9s-zNnMIE#medtherapy>,
        <http://purl.org/np/RAHOVjuu68-bIlVBTAnQbJ2w26zBmjQV-qOLflpxYp7y0#medtherapy> ;
    ns2:signOrSymptom <https://identifiers.org/HP:0002013>,
        <https://identifiers.org/MONDO:0005582> .

<http://purl.obolibrary.org/obo/DOID_12849> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAdTQIUPysHrwinGgjZBSWIPXr35YqudTX8L8LuolXhM4#medtherapy>,
        <http://purl.org/np/RAgaIIsnfQA7eiRx7Ndus9eUFuRlux2-L3CJkbAYDfcw4#medtherapy> ;
    ns2:signOrSymptom <https://identifiers.org/HP:0000737> .

<http://purl.obolibrary.org/obo/DOID_17> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RACsioFt2m0Irt4dynopS-yY4YAY2oAtQRidT7xKFBx4s#medtherapy>,
        <http://purl.org/np/RAIKj8UAyohlByI4G-nU0DUEtg84JfRFoIKapV11I55PE#medtherapy> ;
    ns2:signOrSymptom <http://purl.bioontology.org/ontology/MEDDRA/10013082>,
        <https://identifiers.org/MONDO:0021668> .

<http://purl.obolibrary.org/obo/DOID_1827> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA-IOYDoc_6h1pBW7ctJG2xR4aPrjRet07zzoAZMlXOvI#medtherapy> ;
    ns2:signOrSymptom <https://identifiers.org/HP:0025190> .

<http://purl.obolibrary.org/obo/DOID_3312> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RAudTjRmo213Dadt2UiHwtNCDDkMG9LfrW533mQMpeMwg#medtherapy> ;
    ns2:signOrSymptom <http://purl.bioontology.org/ontology/MEDDRA/10012402>,
        <https://identifiers.org/MONDO:0024612> .

<http://purl.obolibrary.org/obo/MFOMD_0000145> a ns2:MedicalCondition .

<http://purl.obolibrary.org/obo/MFOMD_0000149> a ns2:MedicalCondition .

<http://purl.obolibrary.org/obo/SYMP_0000006> a ns2:MedicalCondition .

<http://purl.obolibrary.org/obo/SYMP_0000099> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA6HE9Y2pKnY9KuKo5piKQwVntoVasRCxBu5S4K1HNtaA#medtherapy>,
        <http://purl.org/np/RA7xnxKCqxMFkwkdj7DEq2XYbhaf5h06yaf3F_0GHDH_M#medtherapy>,
        <http://purl.org/np/RA8MWHh1xLM9bJL-Zo_oXkFhjMMDtViUs7Ro_PK6i5pAI#medtherapy>,
        <http://purl.org/np/RA9KxfwbP2PtJP6RoqGwRYIwoQtxyHlSqTSZ20WfQagFk#medtherapy>,
        <http://purl.org/np/RAEnH0yA4A9l2acjTi7IqOTlhBojOQiuPPiaQFq4xvzrI#medtherapy>,
        <http://purl.org/np/RAGiF9JC-Iv70G0dPvaHai4DtrUF5MtUbB879bWJcJ0U0#medtherapy>,
        <http://purl.org/np/RAIQbr-yR94NBPmMjym9ryVz2yrRE9IeIaAS7WHr6WN5Q#medtherapy>,
        <http://purl.org/np/RAXlqX4ddS9FHfHYeBimA9MJcOGwT9ewT4srEZMnIvWSg#medtherapy>,
        <http://purl.org/np/RAtumd4K7npN3hNOca-3BbxKHlEPACxGb_r44u0Oplw8U#medtherapy>,
        <http://purl.org/np/RAyNDQWKL9XEsT0IiU9fyuO_m_4IOQdS41Sz-G75vipT8#medtherapy> ;
    ns2:signOrSymptom <http://purl.bioontology.org/ontology/SNOMEDCT/48333001>,
        <http://purl.obolibrary.org/obo/SYMP_0000006>,
        <http://purl.obolibrary.org/obo/SYMP_0000438>,
        <http://sbmi.uth.tmc.edu/ontology/ochv#C0718667>,
        <https://identifiers.org/MONDO:0002406>,
        <https://identifiers.org/MONDO:0015137>,
        <https://identifiers.org/MONDO:0021146> .

<http://purl.obolibrary.org/obo/SYMP_0000438> a ns2:MedicalCondition .

<http://purl.org/np/RA-IOYDoc_6h1pBW7ctJG2xR4aPrjRet07zzoAZMlXOvI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        <http://purl.org/np/RA-IOYDoc_6h1pBW7ctJG2xR4aPrjRet07zzoAZMlXOvI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01202> ;
    ns2:targetPopulation <http://purl.org/np/RA-IOYDoc_6h1pBW7ctJG2xR4aPrjRet07zzoAZMlXOvI#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RA-IOYDoc_6h1pBW7ctJG2xR4aPrjRet07zzoAZMlXOvI#quote> ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> .

<http://purl.org/np/RA-IOYDoc_6h1pBW7ctJG2xR4aPrjRet07zzoAZMlXOvI#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult patients (16 years and older)",
        "adult patients and pediatric patients down to the age of 10 years" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_1826>,
        <http://purl.obolibrary.org/obo/DOID_1827> ;
    ns2:requiredMinAge "10",
        "16" .

<http://purl.org/np/RA-SgNkbxNaUjzG2urhUzqWT0slTx7mGl1mV4qaS3cVeg#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "If these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgment, felbamate oral suspension can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37> ],
        <http://purl.org/np/RA-SgNkbxNaUjzG2urhUzqWT0slTx7mGl1mV4qaS3cVeg#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00949> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RA-SgNkbxNaUjzG2urhUzqWT0slTx7mGl1mV4qaS3cVeg#quote> ns1:value "If these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgment, felbamate oral suspension can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37> .

<http://purl.org/np/RA0FfUtTu52nrMkVeP15MAQco8cycJJQJBU-jUfStW-rM#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=346af8fe-3816-49de-bfd3-5a7425e728f9> ],
        <http://purl.org/np/RA0FfUtTu52nrMkVeP15MAQco8cycJJQJBU-jUfStW-rM#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00181> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA0FfUtTu52nrMkVeP15MAQco8cycJJQJBU-jUfStW-rM#quote> ns1:value "Baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=346af8fe-3816-49de-bfd3-5a7425e728f9> .

<http://purl.org/np/RA0Ki-qBZ2Kc2fX9zdtmbQYuqC0SjB2PkhHxawjA_B1TA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "RUZURGI is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2731310a-c060-4d3e-ba41-763d791f63a9> ],
        <http://purl.org/np/RA0Ki-qBZ2Kc2fX9zdtmbQYuqC0SjB2PkhHxawjA_B1TA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB11640> ;
    ns2:targetPopulation <http://purl.org/np/RA0Ki-qBZ2Kc2fX9zdtmbQYuqC0SjB2PkhHxawjA_B1TA#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA0Ki-qBZ2Kc2fX9zdtmbQYuqC0SjB2PkhHxawjA_B1TA#quote> ns1:value "RUZURGI is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2731310a-c060-4d3e-ba41-763d791f63a9> .

<http://purl.org/np/RA0Ki-qBZ2Kc2fX9zdtmbQYuqC0SjB2PkhHxawjA_B1TA#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "patients 6 to less than 17 years of age" ;
    ns2:requiredMaxAge "16" ;
    ns2:requiredMinAge "6" .

<http://purl.org/np/RA0_ZsJUyGmKDHUMgctrXgCR9dGyS_iCMTdz6TQhj0P_o#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "ONGENTYS is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=278a60c4-2353-4657-b486-f392b93181b7> ],
        <http://purl.org/np/RA0_ZsJUyGmKDHUMgctrXgCR9dGyS_iCMTdz6TQhj0P_o#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB11632> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RA0_ZsJUyGmKDHUMgctrXgCR9dGyS_iCMTdz6TQhj0P_o#quote> ns1:value "ONGENTYS is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=278a60c4-2353-4657-b486-f392b93181b7> .

<http://purl.org/np/RA0kL1vIx5GkzRRerK8loobEldBtbzc1QQU-4RovzYqBw#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Protriptyline hydrochloride is indicated for the treatment of symptoms of mental depression in patients who are under close medical supervision." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=700abc58-9362-4ef5-9d7a-dd3c4d364d0a> ],
        <http://purl.org/np/RA0kL1vIx5GkzRRerK8loobEldBtbzc1QQU-4RovzYqBw#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00344> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA0kL1vIx5GkzRRerK8loobEldBtbzc1QQU-4RovzYqBw#quote> ns1:value "Protriptyline hydrochloride is indicated for the treatment of symptoms of mental depression in patients who are under close medical supervision." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=700abc58-9362-4ef5-9d7a-dd3c4d364d0a> .

<http://purl.org/np/RA1DXMXWhyK3Na8qZ1Iujyt6C2VGubEQIfF-22WsrCwXM#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fluoxetine and olanzapine in combination is indicated for the acute treatment of depressive episodes associated with Bipolar I Disorder in adult patients." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> ],
        <http://purl.org/np/RA1DXMXWhyK3Na8qZ1Iujyt6C2VGubEQIfF-22WsrCwXM#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00472> ;
    ns2:targetPopulation <http://purl.org/np/RA1DXMXWhyK3Na8qZ1Iujyt6C2VGubEQIfF-22WsrCwXM#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA1DXMXWhyK3Na8qZ1Iujyt6C2VGubEQIfF-22WsrCwXM#quote> ns1:value "Fluoxetine and olanzapine in combination is indicated for the acute treatment of depressive episodes associated with Bipolar I Disorder in adult patients." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> .

<http://purl.org/np/RA1DXMXWhyK3Na8qZ1Iujyt6C2VGubEQIfF-22WsrCwXM#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult patients" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_3312> ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RA1a_8AKy1hdB1myNdczSEYJ_nYQ6Vt4zp6z6KKvbvFCI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> ],
        <http://purl.org/np/RA1a_8AKy1hdB1myNdczSEYJ_nYQ6Vt4zp6z6KKvbvFCI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01068> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA1a_8AKy1hdB1myNdczSEYJ_nYQ6Vt4zp6z6KKvbvFCI#quote> ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> .

<http://purl.org/np/RA27UP6-CU0WWNQ_DYbv43lw1lBw_19egfMwBs4r4yyYA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Milnacipran HCl tablets are indicated for the management of fibromyalgia." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eaa14195-1b9c-423c-9412-d2fe0857e39d> ],
        <http://purl.org/np/RA27UP6-CU0WWNQ_DYbv43lw1lBw_19egfMwBs4r4yyYA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB04896> ;
    ns2:targetPopulation <http://purl.org/np/RA27UP6-CU0WWNQ_DYbv43lw1lBw_19egfMwBs4r4yyYA#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA27UP6-CU0WWNQ_DYbv43lw1lBw_19egfMwBs4r4yyYA#quote> ns1:value "Milnacipran HCl tablets are indicated for the management of fibromyalgia." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eaa14195-1b9c-423c-9412-d2fe0857e39d> .

<http://purl.org/np/RA27UP6-CU0WWNQ_DYbv43lw1lBw_19egfMwBs4r4yyYA#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "not approved for use in pediatric patients" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RA27c2O-kozxjC5IefxMGSneu-bQmje9BqVj8pYVI1uVk#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older:  partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> ],
        <http://purl.org/np/RA27c2O-kozxjC5IefxMGSneu-bQmje9BqVj8pYVI1uVk#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00555> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RA27c2O-kozxjC5IefxMGSneu-bQmje9BqVj8pYVI1uVk#quote> ns1:value "Lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older:  partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> .

<http://purl.org/np/RA2UOITfDMkzWKcRckikJC6a_2-iErW8LZZ5cYDXfBmCQ#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1967dc24-f2a5-4095-baa9-a9d1c5410311> ],
        <http://purl.org/np/RA2UOITfDMkzWKcRckikJC6a_2-iErW8LZZ5cYDXfBmCQ#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00623> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA2UOITfDMkzWKcRckikJC6a_2-iErW8LZZ5cYDXfBmCQ#quote> ns1:value "Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1967dc24-f2a5-4095-baa9-a9d1c5410311> .

<http://purl.org/np/RA2Zis4uKzCdct67hojX4TfPY-SrgLlo-wF-Dvm044xwc#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Tizanidine hydrochloride capsules are central alpha-2-adrenergic agonist indicated for the management of spasticity" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e19636a4-3c5e-4b75-b394-003098f74d48> ],
        <http://purl.org/np/RA2Zis4uKzCdct67hojX4TfPY-SrgLlo-wF-Dvm044xwc#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00697> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA2Zis4uKzCdct67hojX4TfPY-SrgLlo-wF-Dvm044xwc#quote> ns1:value "Tizanidine hydrochloride capsules are central alpha-2-adrenergic agonist indicated for the management of spasticity" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e19636a4-3c5e-4b75-b394-003098f74d48> .

<http://purl.org/np/RA2dQdtUAn_I3jvaTARl3nKZEstqyINdsDa0rCa2Oxyec#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> ],
        <http://purl.org/np/RA2dQdtUAn_I3jvaTARl3nKZEstqyINdsDa0rCa2Oxyec#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00555> ;
    ns3:indicationType ns2:PreventionIndication .

<http://purl.org/np/RA2dQdtUAn_I3jvaTARl3nKZEstqyINdsDa0rCa2Oxyec#quote> ns1:value "Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> .

<http://purl.org/np/RA2tgUbYrtdDIcmFOCcHBxnXXrFJRsvUfLMvBDnXyW1kY#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RA2tgUbYrtdDIcmFOCcHBxnXXrFJRsvUfLMvBDnXyW1kY#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RA2tgUbYrtdDIcmFOCcHBxnXXrFJRsvUfLMvBDnXyW1kY#quote> ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RA2zKLyAuyeo6cHTfOknawUYaRg4M4pUeliAern9R_sJ8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clozapine is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25c0c6d5-f7b0-48e4-e054-00144ff8d46c> ],
        <http://purl.org/np/RA2zKLyAuyeo6cHTfOknawUYaRg4M4pUeliAern9R_sJ8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00363> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA2zKLyAuyeo6cHTfOknawUYaRg4M4pUeliAern9R_sJ8#quote> ns1:value "Clozapine is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25c0c6d5-f7b0-48e4-e054-00144ff8d46c> .

<http://purl.org/np/RA3TnVWbjO2l5MATOgoyN_4nZDAqWn4iIiTUrestt0iNs#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Cevimeline hydrochloride capsules are indicated for the treatment of symptoms of dry mouth in patients with Sjögren’s Syndrome." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=773a19e8-4c3e-4414-99a6-aea98c9790ee> ],
        [ ns1:value "Cevimeline hydrochloride capsules are indicated for the treatment of symptoms of dry mouth in patients with Sjögren’s Syndrome." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=773a19e8-4c3e-4414-99a6-aea98c9790ee> ],
        [ ns1:value "Cevimeline hydrochloride capsules are indicated for the treatment of symptoms of dry mouth in patients with Sjögren’s Syndrome." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=773a19e8-4c3e-4414-99a6-aea98c9790ee> ],
        <http://purl.org/np/RA3TnVWbjO2l5MATOgoyN_4nZDAqWn4iIiTUrestt0iNs#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00185> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA3TnVWbjO2l5MATOgoyN_4nZDAqWn4iIiTUrestt0iNs#quote> ns1:value "Cevimeline hydrochloride capsules are indicated for the treatment of symptoms of dry mouth in patients with Sjögren’s Syndrome." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=773a19e8-4c3e-4414-99a6-aea98c9790ee> .

<http://purl.org/np/RA4NxwTQlS0Lyc3lrJ3qp73SKnXhmPWoNYqd9s-zNnMIE#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of binge-eating and vomiting behaviors in adult patients with moderate to severe Bulimia Nervosa" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> ],
        <http://purl.org/np/RA4NxwTQlS0Lyc3lrJ3qp73SKnXhmPWoNYqd9s-zNnMIE#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00472> ;
    ns2:targetPopulation <http://purl.org/np/RA4NxwTQlS0Lyc3lrJ3qp73SKnXhmPWoNYqd9s-zNnMIE#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA4NxwTQlS0Lyc3lrJ3qp73SKnXhmPWoNYqd9s-zNnMIE#quote> ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of binge-eating and vomiting behaviors in adult patients with moderate to severe Bulimia Nervosa" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> .

<http://purl.org/np/RA4NxwTQlS0Lyc3lrJ3qp73SKnXhmPWoNYqd9s-zNnMIE#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult patients" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_12129> ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RA4RQidK46yolCNNlZoDetKG69PuKVS91_RIlGlUx3jgk#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Quetiapine tablets are indicated as monotherapy for the acute treatment of depressive episodes associated with bipolar disorder." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=904f80af-44b6-d964-1680-ac9e6b61327b> ],
        <http://purl.org/np/RA4RQidK46yolCNNlZoDetKG69PuKVS91_RIlGlUx3jgk#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01224> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA4RQidK46yolCNNlZoDetKG69PuKVS91_RIlGlUx3jgk#quote> ns1:value "Quetiapine tablets are indicated as monotherapy for the acute treatment of depressive episodes associated with bipolar disorder." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=904f80af-44b6-d964-1680-ac9e6b61327b> .

<http://purl.org/np/RA4koEJfDMV1MAAlmLJb4gOPQERvwMAgi4DtfWxBwW-io#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b255bcd-0218-44f8-830b-971f5ec45276> ],
        <http://purl.org/np/RA4koEJfDMV1MAAlmLJb4gOPQERvwMAgi4DtfWxBwW-io#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00371> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA4koEJfDMV1MAAlmLJb4gOPQERvwMAgi4DtfWxBwW-io#quote> ns1:value "Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b255bcd-0218-44f8-830b-971f5ec45276> .

<http://purl.org/np/RA4wuBZAwMlQapNzm2ER6CdJP__bCKkD9yN_J3Ht0DH80#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f6bea0c-297b-43ff-8960-ecc11243e06e> ],
        <http://purl.org/np/RA4wuBZAwMlQapNzm2ER6CdJP__bCKkD9yN_J3Ht0DH80#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00289> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA4wuBZAwMlQapNzm2ER6CdJP__bCKkD9yN_J3Ht0DH80#quote> ns1:value "Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f6bea0c-297b-43ff-8960-ecc11243e06e> .

<http://purl.org/np/RA5zceJYEHlV2wTGXpWO9fMyCRP__HDYEwYxNYI83eUDg#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebe34db4-816d-4f0a-adbb-826693662754> ],
        <http://purl.org/np/RA5zceJYEHlV2wTGXpWO9fMyCRP__HDYEwYxNYI83eUDg#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00230> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA5zceJYEHlV2wTGXpWO9fMyCRP__HDYEwYxNYI83eUDg#quote> ns1:value "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebe34db4-816d-4f0a-adbb-826693662754> .

<http://purl.org/np/RA6HE9Y2pKnY9KuKo5piKQwVntoVasRCxBu5S4K1HNtaA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Uses: temporarily reduces pains and aches due to headache, toothache, backache, menstrual cramps, the common cold, muscular aches, minor pains of arthritis, temporarily reduces fever" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c65b691-b795-44a5-abb7-931cd772f1a1> ],
        <http://purl.org/np/RA6HE9Y2pKnY9KuKo5piKQwVntoVasRCxBu5S4K1HNtaA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01050> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA6HE9Y2pKnY9KuKo5piKQwVntoVasRCxBu5S4K1HNtaA#quote> ns1:value "Uses: temporarily reduces pains and aches due to headache, toothache, backache, menstrual cramps, the common cold, muscular aches, minor pains of arthritis, temporarily reduces fever" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c65b691-b795-44a5-abb7-931cd772f1a1> .

<http://purl.org/np/RA6YjOCgmeoLeClhT2jjHtKulbRyBJPPLYA9HyvbNcsPw#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Sertraline tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (OCD), as defined in the DSM-III-R; i.e., the obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> ],
        <http://purl.org/np/RA6YjOCgmeoLeClhT2jjHtKulbRyBJPPLYA9HyvbNcsPw#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB08567> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA6YjOCgmeoLeClhT2jjHtKulbRyBJPPLYA9HyvbNcsPw#quote> ns1:value "Sertraline tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (OCD), as defined in the DSM-III-R; i.e., the obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> .

<http://purl.org/np/RA6j9ngf7h2h_jWjqkJdM_RcToQpooMUEHVd1BWzIH5ys#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "ARICEPT® is indicated for the treatment of dementia of the Alzheimer's type." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b1b7b5f-2f20-418c-b1ac-794c2ef1ce5e> ],
        <http://purl.org/np/RA6j9ngf7h2h_jWjqkJdM_RcToQpooMUEHVd1BWzIH5ys#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00843> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA6j9ngf7h2h_jWjqkJdM_RcToQpooMUEHVd1BWzIH5ys#quote> ns1:value "ARICEPT® is indicated for the treatment of dementia of the Alzheimer's type." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b1b7b5f-2f20-418c-b1ac-794c2ef1ce5e> .

<http://purl.org/np/RA6nLgKKumV3t178HnkFMr_bsi_dnfbB3g3NEEgNakmTU#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscoskeletal Pain" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea2dc1a6-22d5-4295-9d39-9bf015dc5a89> ],
        <http://purl.org/np/RA6nLgKKumV3t178HnkFMr_bsi_dnfbB3g3NEEgNakmTU#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00476> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA6nLgKKumV3t178HnkFMr_bsi_dnfbB3g3NEEgNakmTU#quote> ns1:value "Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscoskeletal Pain" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea2dc1a6-22d5-4295-9d39-9bf015dc5a89> .

<http://purl.org/np/RA7ZXjeMdR-Oj8cSGBHc1QT3bybQL8lvNNcnJEfqWfaSA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e6bea44-57d6-4bac-9328-46e1ee59f83b> ],
        <http://purl.org/np/RA7ZXjeMdR-Oj8cSGBHc1QT3bybQL8lvNNcnJEfqWfaSA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB05316> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA7ZXjeMdR-Oj8cSGBHc1QT3bybQL8lvNNcnJEfqWfaSA#quote> ns1:value "NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e6bea44-57d6-4bac-9328-46e1ee59f83b> .

<http://purl.org/np/RA7cGOVqnmN7UlaCf_WNPt8wIwxbEi4tbUttnQ6hb55ig#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebe34db4-816d-4f0a-adbb-826693662754> ],
        <http://purl.org/np/RA7cGOVqnmN7UlaCf_WNPt8wIwxbEi4tbUttnQ6hb55ig#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00230> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA7cGOVqnmN7UlaCf_WNPt8wIwxbEi4tbUttnQ6hb55ig#quote> ns1:value "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebe34db4-816d-4f0a-adbb-826693662754> .

<http://purl.org/np/RA7uwFdY5LZlJRTAEgfdqOic3d7fCyivtmJfmSPNMLvDE#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Its activating properties make it particularly suitable for withdrawn and anergic patients." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=700abc58-9362-4ef5-9d7a-dd3c4d364d0a> ],
        <http://purl.org/np/RA7uwFdY5LZlJRTAEgfdqOic3d7fCyivtmJfmSPNMLvDE#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00344> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA7uwFdY5LZlJRTAEgfdqOic3d7fCyivtmJfmSPNMLvDE#quote> ns1:value "Its activating properties make it particularly suitable for withdrawn and anergic patients." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=700abc58-9362-4ef5-9d7a-dd3c4d364d0a> .

<http://purl.org/np/RA7xnxKCqxMFkwkdj7DEq2XYbhaf5h06yaf3F_0GHDH_M#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Uses - temporarily relieves minor aches and pains due to: minor pain of arthritis, backache, headache, muscular aches, menstrual cramps, toothache, common cold, temporarily reduces fever" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc5ddcf2-640c-4683-a60f-ca1c8b418873> ],
        <http://purl.org/np/RA7xnxKCqxMFkwkdj7DEq2XYbhaf5h06yaf3F_0GHDH_M#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00788> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA7xnxKCqxMFkwkdj7DEq2XYbhaf5h06yaf3F_0GHDH_M#quote> ns1:value "Uses - temporarily relieves minor aches and pains due to: minor pain of arthritis, backache, headache, muscular aches, menstrual cramps, toothache, common cold, temporarily reduces fever" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc5ddcf2-640c-4683-a60f-ca1c8b418873> .

<http://purl.org/np/RA83ToxRvM673udY2pWq9hw_0ctIY-kZX9LL5IhMDr73o#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7e467c02-49a0-4b62-b537-430fdfa4f10e> ],
        <http://purl.org/np/RA83ToxRvM673udY2pWq9hw_0ctIY-kZX9LL5IhMDr73o#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00252> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA83ToxRvM673udY2pWq9hw_0ctIY-kZX9LL5IhMDr73o#quote> ns1:value "Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7e467c02-49a0-4b62-b537-430fdfa4f10e> .

<http://purl.org/np/RA8MWHh1xLM9bJL-Zo_oXkFhjMMDtViUs7Ro_PK6i5pAI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Diclofenac potassium tablets are indicated:For relief of mild to moderate pain" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=77b60a0c-e49a-4ad4-abb1-b662c24ab782> ],
        <http://purl.org/np/RA8MWHh1xLM9bJL-Zo_oXkFhjMMDtViUs7Ro_PK6i5pAI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00586> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA8MWHh1xLM9bJL-Zo_oXkFhjMMDtViUs7Ro_PK6i5pAI#quote> ns1:value "Diclofenac potassium tablets are indicated:For relief of mild to moderate pain" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=77b60a0c-e49a-4ad4-abb1-b662c24ab782> .

<http://purl.org/np/RA8vJY1e5gl8Te-Qver4whvJa9OHvBp2lRHH6DdPBUeNU#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "For temporary relief of symptoms related to sleep disorders, Seasonal Affective Disorder, jet lag, and depression." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fdaf86c2-137d-4926-a63b-9faf7ec7e04c> ],
        <http://purl.org/np/RA8vJY1e5gl8Te-Qver4whvJa9OHvBp2lRHH6DdPBUeNU#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01065> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA8vJY1e5gl8Te-Qver4whvJa9OHvBp2lRHH6DdPBUeNU#quote> ns1:value "For temporary relief of symptoms related to sleep disorders, Seasonal Affective Disorder, jet lag, and depression." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fdaf86c2-137d-4926-a63b-9faf7ec7e04c> .

<http://purl.org/np/RA8x6sYMM9dSQgjWIlzaFVZBhsanO4CPEQp1Szow4y32E#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fluoxetine is indicated for the acute treatment of Panic Disorder, with or without agoraphobia, in adult patients" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> ],
        <http://purl.org/np/RA8x6sYMM9dSQgjWIlzaFVZBhsanO4CPEQp1Szow4y32E#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00472> ;
    ns2:targetPopulation <http://purl.org/np/RA8x6sYMM9dSQgjWIlzaFVZBhsanO4CPEQp1Szow4y32E#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA8x6sYMM9dSQgjWIlzaFVZBhsanO4CPEQp1Szow4y32E#quote> ns1:value "Fluoxetine is indicated for the acute treatment of Panic Disorder, with or without agoraphobia, in adult patients" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> .

<http://purl.org/np/RA8x6sYMM9dSQgjWIlzaFVZBhsanO4CPEQp1Szow4y32E#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult patients" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RA93ZLqk55xHV2AgL_HqnQabkJwAdiN9UgtAV_Mw-GgDs#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Ropinirole tablets are indicated for the treatment of Parkinson’s disease" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5ce07b9-ad0d-4b72-9daf-8662775af093> ],
        <http://purl.org/np/RA93ZLqk55xHV2AgL_HqnQabkJwAdiN9UgtAV_Mw-GgDs#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00268> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA93ZLqk55xHV2AgL_HqnQabkJwAdiN9UgtAV_Mw-GgDs#quote> ns1:value "Ropinirole tablets are indicated for the treatment of Parkinson’s disease" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5ce07b9-ad0d-4b72-9daf-8662775af093> .

<http://purl.org/np/RA9EAQSYqhe0uJj1xN-XEVCuY1K-sFIB1KtI4gBA9GBdw#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Additionally, [Trihexyphenidyl] is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6f08000-e973-4bab-810c-b69f6c8ee4f3> ],
        <http://purl.org/np/RA9EAQSYqhe0uJj1xN-XEVCuY1K-sFIB1KtI4gBA9GBdw#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00376> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA9EAQSYqhe0uJj1xN-XEVCuY1K-sFIB1KtI4gBA9GBdw#quote> ns1:value "Additionally, [Trihexyphenidyl] is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6f08000-e973-4bab-810c-b69f6c8ee4f3> .

<http://purl.org/np/RA9HbDSDxk8nMofWUuSzBgf4DXrb195jxJomi6wtYdG18#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RA9HbDSDxk8nMofWUuSzBgf4DXrb195jxJomi6wtYdG18#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA9HbDSDxk8nMofWUuSzBgf4DXrb195jxJomi6wtYdG18#quote> ns1:value "In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RA9KxfwbP2PtJP6RoqGwRYIwoQtxyHlSqTSZ20WfQagFk#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "As an antiaggregant in antiplatelet therapy or for temporary relief of minor aches and pains." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80ce8064-0e27-4587-b70b-2ea3c9aa2786> ],
        <http://purl.org/np/RA9KxfwbP2PtJP6RoqGwRYIwoQtxyHlSqTSZ20WfQagFk#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00945> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA9KxfwbP2PtJP6RoqGwRYIwoQtxyHlSqTSZ20WfQagFk#quote> ns1:value "As an antiaggregant in antiplatelet therapy or for temporary relief of minor aches and pains." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80ce8064-0e27-4587-b70b-2ea3c9aa2786> .

<http://purl.org/np/RA9_oHh9PXx4BzNI0D2uJ5GLqhzGFHnlwJhg2ILZY_Zh4#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Zolpidem Tartrate Tablets is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=021153ce-fe27-4ed1-8d88-b4157b0ed734> ],
        <http://purl.org/np/RA9_oHh9PXx4BzNI0D2uJ5GLqhzGFHnlwJhg2ILZY_Zh4#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00425> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RA9_oHh9PXx4BzNI0D2uJ5GLqhzGFHnlwJhg2ILZY_Zh4#quote> ns1:value "Zolpidem Tartrate Tablets is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=021153ce-fe27-4ed1-8d88-b4157b0ed734> .

<http://purl.org/np/RA9vXvECxARQAwEJ3GZEevkv225IOuaobDjGoXt4jUOH8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RA9vXvECxARQAwEJ3GZEevkv225IOuaobDjGoXt4jUOH8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RA9vXvECxARQAwEJ3GZEevkv225IOuaobDjGoXt4jUOH8#quote> ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RAAYpMR8lAxvV-aA4H_x7yABI_huscMEusKa1lc0AET_o#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Sertraline tablets are indicated for the treatment of panic disorder in adults, with or without agoraphobia, as defined in DSM-IV." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> ],
        <http://purl.org/np/RAAYpMR8lAxvV-aA4H_x7yABI_huscMEusKa1lc0AET_o#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB08567> ;
    ns2:targetPopulation <http://purl.org/np/RAAYpMR8lAxvV-aA4H_x7yABI_huscMEusKa1lc0AET_o#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAAYpMR8lAxvV-aA4H_x7yABI_huscMEusKa1lc0AET_o#quote> ns1:value "Sertraline tablets are indicated for the treatment of panic disorder in adults, with or without agoraphobia, as defined in DSM-IV." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> .

<http://purl.org/np/RAAYpMR8lAxvV-aA4H_x7yABI_huscMEusKa1lc0AET_o#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAB8au2sKSsDGwwtswkhDSAXbiDF97-t4CXDDxbFw3DX0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression)" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afad3051-9df2-4c54-9684-e8262a133af8> ],
        <http://purl.org/np/RAB8au2sKSsDGwwtswkhDSAXbiDF97-t4CXDDxbFw3DX0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB08815> ;
    ns2:targetPopulation <http://purl.org/np/RAB8au2sKSsDGwwtswkhDSAXbiDF97-t4CXDDxbFw3DX0#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAB8au2sKSsDGwwtswkhDSAXbiDF97-t4CXDDxbFw3DX0#quote> ns1:value "Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression)" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afad3051-9df2-4c54-9684-e8262a133af8> .

<http://purl.org/np/RAB8au2sKSsDGwwtswkhDSAXbiDF97-t4CXDDxbFw3DX0#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult and pediatric patients (10 to 17 years)" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_14042> ;
    ns2:requiredMinAge "10" .

<http://purl.org/np/RABS0ugQRHw6nqKlTste8ONPF8P3T9lUSA8alAK0aZIU0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Sertraline is indicated for the treatment of posttraumatic stress disorder in adults." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> ],
        <http://purl.org/np/RABS0ugQRHw6nqKlTste8ONPF8P3T9lUSA8alAK0aZIU0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB08567> ;
    ns2:targetPopulation <http://purl.org/np/RABS0ugQRHw6nqKlTste8ONPF8P3T9lUSA8alAK0aZIU0#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RABS0ugQRHw6nqKlTste8ONPF8P3T9lUSA8alAK0aZIU0#quote> ns1:value "Sertraline is indicated for the treatment of posttraumatic stress disorder in adults." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> .

<http://purl.org/np/RABS0ugQRHw6nqKlTste8ONPF8P3T9lUSA8alAK0aZIU0#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RABbDk6fspKPxhoo9lIYlJNFKbRhurBS31Y7WLhMWMoVc#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Quazepam is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f7d63f3f-5303-48ab-bce2-35fd62c45799> ],
        <http://purl.org/np/RABbDk6fspKPxhoo9lIYlJNFKbRhurBS31Y7WLhMWMoVc#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01589> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RABbDk6fspKPxhoo9lIYlJNFKbRhurBS31Y7WLhMWMoVc#quote> ns1:value "Quazepam is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f7d63f3f-5303-48ab-bce2-35fd62c45799> .

<http://purl.org/np/RABhtK76h7GF2p3ZqFYRVL_si6QSJF9b2syqKHwJC2scE#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Phenelzine Sulfate Tablets, USP has been found to be effective in depressed patients clinically characterized as \"atypical,\" \"nonendogenous,\" or \"neurotic.\"" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40483372-448f-4284-976c-8462ef256661> ],
        <http://purl.org/np/RABhtK76h7GF2p3ZqFYRVL_si6QSJF9b2syqKHwJC2scE#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00780> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RABhtK76h7GF2p3ZqFYRVL_si6QSJF9b2syqKHwJC2scE#quote> ns1:value "Phenelzine Sulfate Tablets, USP has been found to be effective in depressed patients clinically characterized as \"atypical,\" \"nonendogenous,\" or \"neurotic.\"" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40483372-448f-4284-976c-8462ef256661> .

<http://purl.org/np/RACsioFt2m0Irt4dynopS-yY4YAY2oAtQRidT7xKFBx4s#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42c0a177-7d62-4bcf-9fce-7dd484cda4d5> ],
        <http://purl.org/np/RACsioFt2m0Irt4dynopS-yY4YAY2oAtQRidT7xKFBx4s#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00423> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RACsioFt2m0Irt4dynopS-yY4YAY2oAtQRidT7xKFBx4s#quote> ns1:value "Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42c0a177-7d62-4bcf-9fce-7dd484cda4d5> .

<http://purl.org/np/RACt5hvoATSAT196jCJRi4IZcPTOkx2mOmJn8HNNP161E#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> ],
        <http://purl.org/np/RACt5hvoATSAT196jCJRi4IZcPTOkx2mOmJn8HNNP161E#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01068> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RACt5hvoATSAT196jCJRi4IZcPTOkx2mOmJn8HNNP161E#quote> ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> .

<http://purl.org/np/RACwmZC5WsfNbesSttEo1SI2ZR8uWA412-VbtAIVQ8wJI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Topiramate tablets and topiramate capsules are indicated as adjunctive therapy for for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b> ],
        <http://purl.org/np/RACwmZC5WsfNbesSttEo1SI2ZR8uWA412-VbtAIVQ8wJI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00273> ;
    ns2:targetPopulation <http://purl.org/np/RACwmZC5WsfNbesSttEo1SI2ZR8uWA412-VbtAIVQ8wJI#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RACwmZC5WsfNbesSttEo1SI2ZR8uWA412-VbtAIVQ8wJI#quote> ns1:value "Topiramate tablets and topiramate capsules are indicated as adjunctive therapy for for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b> .

<http://purl.org/np/RACwmZC5WsfNbesSttEo1SI2ZR8uWA412-VbtAIVQ8wJI#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "patients 2 years of age and older" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_0050561> ;
    ns2:requiredMinAge "2" .

<http://purl.org/np/RAD8RAc3Apj670ag8pPgYT4x-ALud7gy_4Pfkv2ntj3I8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Diazepam injection is a useful adjunct in status epilepticus and severe recurrent convulsive seizures." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RAD8RAc3Apj670ag8pPgYT4x-ALud7gy_4Pfkv2ntj3I8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAD8RAc3Apj670ag8pPgYT4x-ALud7gy_4Pfkv2ntj3I8#quote> ns1:value "Diazepam injection is a useful adjunct in status epilepticus and severe recurrent convulsive seizures." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RADAM9VAVOWerQuwFfwMyD-gDOteafAwQYwW4JgHsQJN4#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed3039d8-3d27-4b71-a4b0-812943c9457f> ],
        <http://purl.org/np/RADAM9VAVOWerQuwFfwMyD-gDOteafAwQYwW4JgHsQJN4#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00656> ;
    ns2:targetPopulation <http://purl.org/np/RADAM9VAVOWerQuwFfwMyD-gDOteafAwQYwW4JgHsQJN4#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RADAM9VAVOWerQuwFfwMyD-gDOteafAwQYwW4JgHsQJN4#quote> ns1:value "Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed3039d8-3d27-4b71-a4b0-812943c9457f> .

<http://purl.org/np/RADAM9VAVOWerQuwFfwMyD-gDOteafAwQYwW4JgHsQJN4#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RADpzcvCoFfLrH_m6PIbEyrpTBI0TDVgbzTaIBgKortag#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RADpzcvCoFfLrH_m6PIbEyrpTBI0TDVgbzTaIBgKortag#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RADpzcvCoFfLrH_m6PIbEyrpTBI0TDVgbzTaIBgKortag#quote> ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RADxMF96mfnO8Lkpdn3dsherznOvalMYi4COH8IeGyqNE#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscoskeletal Pain" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea2dc1a6-22d5-4295-9d39-9bf015dc5a89> ],
        <http://purl.org/np/RADxMF96mfnO8Lkpdn3dsherznOvalMYi4COH8IeGyqNE#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00476> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RADxMF96mfnO8Lkpdn3dsherznOvalMYi4COH8IeGyqNE#quote> ns1:value "Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscoskeletal Pain" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea2dc1a6-22d5-4295-9d39-9bf015dc5a89> .

<http://purl.org/np/RAEnH0yA4A9l2acjTi7IqOTlhBojOQiuPPiaQFq4xvzrI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Hydrocodone Bitartrate Extended-Release Capsules are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7b8ea07-e926-f0a5-c20d-92f23ed350d0> ],
        <http://purl.org/np/RAEnH0yA4A9l2acjTi7IqOTlhBojOQiuPPiaQFq4xvzrI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00956> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAEnH0yA4A9l2acjTi7IqOTlhBojOQiuPPiaQFq4xvzrI#quote> ns1:value "Hydrocodone Bitartrate Extended-Release Capsules are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7b8ea07-e926-f0a5-c20d-92f23ed350d0> .

<http://purl.org/np/RAEq0Fo5IgBKowfdrbtsSqqhpGxzuAdvVB8s3W5uVryic#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb1a3d20-1f93-48a1-9e27-4712a8561757> ],
        <http://purl.org/np/RAEq0Fo5IgBKowfdrbtsSqqhpGxzuAdvVB8s3W5uVryic#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00850> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAEq0Fo5IgBKowfdrbtsSqqhpGxzuAdvVB8s3W5uVryic#quote> ns1:value "Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb1a3d20-1f93-48a1-9e27-4712a8561757> .

<http://purl.org/np/RAGN7ijOmDfmPgBu7OHccNwALSaa_a8iulT6KR1VIh8F8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Risperidone tablets are indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in Adults" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> ],
        <http://purl.org/np/RAGN7ijOmDfmPgBu7OHccNwALSaa_a8iulT6KR1VIh8F8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00734> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAGN7ijOmDfmPgBu7OHccNwALSaa_a8iulT6KR1VIh8F8#quote> ns1:value "Risperidone tablets are indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in Adults" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> .

<http://purl.org/np/RAGWb7x_-l63jDaRH1e6Edf3hImTqvB_dOYXWNq3AbDgE#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Entacapone tablets are indicated as an adjunct to levodopa and carbidopa to treat end-of-dose “wearing-off” in patients with Parkinson’s disease" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9e94e9f-cd7a-45f5-9aeb-9c28ed804d8c> ],
        <http://purl.org/np/RAGWb7x_-l63jDaRH1e6Edf3hImTqvB_dOYXWNq3AbDgE#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00494> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAGWb7x_-l63jDaRH1e6Edf3hImTqvB_dOYXWNq3AbDgE#quote> ns1:value "Entacapone tablets are indicated as an adjunct to levodopa and carbidopa to treat end-of-dose “wearing-off” in patients with Parkinson’s disease" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9e94e9f-cd7a-45f5-9aeb-9c28ed804d8c> .

<http://purl.org/np/RAGiF9JC-Iv70G0dPvaHai4DtrUF5MtUbB879bWJcJ0U0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Morphine sulfate is indicated for the relief of severe pain. The use of morphine for the relief of pain should be reserved for the more severe manifestations of pain, as in myocardial infarction,severe injuries, or in severe chronic pain associated with terminal cancer after all non-narcotic analgesics have failed." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e360d6b6-d9ef-487d-bf14-fcbbee8beb29> ],
        <http://purl.org/np/RAGiF9JC-Iv70G0dPvaHai4DtrUF5MtUbB879bWJcJ0U0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00295> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAGiF9JC-Iv70G0dPvaHai4DtrUF5MtUbB879bWJcJ0U0#quote> ns1:value "Morphine sulfate is indicated for the relief of severe pain. The use of morphine for the relief of pain should be reserved for the more severe manifestations of pain, as in myocardial infarction,severe injuries, or in severe chronic pain associated with terminal cancer after all non-narcotic analgesics have failed." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e360d6b6-d9ef-487d-bf14-fcbbee8beb29> .

<http://purl.org/np/RAGqE-5Za5IIEDuOvf5-9jdhn2B9f2dfCgp4zhTSYw_1w#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Escitalopram oral solution, USP is indicated for the acute treatment of Generalized Anxiety Disorder (GAD) in adults" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c871d3fe-5ca2-410c-976d-9ec4b72c878f> ],
        <http://purl.org/np/RAGqE-5Za5IIEDuOvf5-9jdhn2B9f2dfCgp4zhTSYw_1w#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01175> ;
    ns2:targetPopulation <http://purl.org/np/RAGqE-5Za5IIEDuOvf5-9jdhn2B9f2dfCgp4zhTSYw_1w#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAGqE-5Za5IIEDuOvf5-9jdhn2B9f2dfCgp4zhTSYw_1w#quote> ns1:value "Escitalopram oral solution, USP is indicated for the acute treatment of Generalized Anxiety Disorder (GAD) in adults" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c871d3fe-5ca2-410c-976d-9ec4b72c878f> .

<http://purl.org/np/RAGqE-5Za5IIEDuOvf5-9jdhn2B9f2dfCgp4zhTSYw_1w#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAGr5IIjcYVTGqbOorqy5jy1Xqh1CTwdlCnnSmjUMfGUE#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Quetiapine tablets are indicated for the acute treatment of manic episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or divalproex" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=904f80af-44b6-d964-1680-ac9e6b61327b> ],
        <http://purl.org/np/RAGr5IIjcYVTGqbOorqy5jy1Xqh1CTwdlCnnSmjUMfGUE#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01224> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAGr5IIjcYVTGqbOorqy5jy1Xqh1CTwdlCnnSmjUMfGUE#quote> ns1:value "Quetiapine tablets are indicated for the acute treatment of manic episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or divalproex" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=904f80af-44b6-d964-1680-ac9e6b61327b> .

<http://purl.org/np/RAGyQL6v2QGO00ttIPrkeFIYwg2fgmfo5jTbws6jmWbes#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: Narcolepsy" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d40847-e0d3-48ec-81a7-ec5478553565> ],
        <http://purl.org/np/RAGyQL6v2QGO00ttIPrkeFIYwg2fgmfo5jTbws6jmWbes#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00182> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAGyQL6v2QGO00ttIPrkeFIYwg2fgmfo5jTbws6jmWbes#quote> ns1:value "Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: Narcolepsy" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d40847-e0d3-48ec-81a7-ec5478553565> .

<http://purl.org/np/RAHOVjuu68-bIlVBTAnQbJ2w26zBmjQV-qOLflpxYp7y0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of binge-eating and vomiting behaviors in adult patients with moderate to severe Bulimia Nervosa" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> ],
        <http://purl.org/np/RAHOVjuu68-bIlVBTAnQbJ2w26zBmjQV-qOLflpxYp7y0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00472> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAHOVjuu68-bIlVBTAnQbJ2w26zBmjQV-qOLflpxYp7y0#quote> ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of binge-eating and vomiting behaviors in adult patients with moderate to severe Bulimia Nervosa" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> .

<http://purl.org/np/RAIKj8UAyohlByI4G-nU0DUEtg84JfRFoIKapV11I55PE#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Carisoprodol Tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab22f1be-16c8-45b6-adaf-09e08bf7a545> ],
        <http://purl.org/np/RAIKj8UAyohlByI4G-nU0DUEtg84JfRFoIKapV11I55PE#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00395> ;
    ns2:targetPopulation <http://purl.org/np/RAIKj8UAyohlByI4G-nU0DUEtg84JfRFoIKapV11I55PE#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAIKj8UAyohlByI4G-nU0DUEtg84JfRFoIKapV11I55PE#quote> ns1:value "Carisoprodol Tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab22f1be-16c8-45b6-adaf-09e08bf7a545> .

<http://purl.org/np/RAIKj8UAyohlByI4G-nU0DUEtg84JfRFoIKapV11I55PE#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_17> ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAIN0sRstQjV1KQlD36mmiibST08Ot_3Qlrmm6Ha7GGr8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Quetiapine tablets are indicated for the treatment of schizophrenia" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=904f80af-44b6-d964-1680-ac9e6b61327b> ],
        <http://purl.org/np/RAIN0sRstQjV1KQlD36mmiibST08Ot_3Qlrmm6Ha7GGr8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01224> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAIN0sRstQjV1KQlD36mmiibST08Ot_3Qlrmm6Ha7GGr8#quote> ns1:value "Quetiapine tablets are indicated for the treatment of schizophrenia" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=904f80af-44b6-d964-1680-ac9e6b61327b> .

<http://purl.org/np/RAIQbr-yR94NBPmMjym9ryVz2yrRE9IeIaAS7WHr6WN5Q#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Morphine sulfate is indicated for the relief of severe pain. The use of morphine for the relief of pain should be reserved for the more severe manifestations of pain, as in myocardial infarction,severe injuries, or in severe chronic pain associated with terminal cancer after all non-narcotic analgesics have failed." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e360d6b6-d9ef-487d-bf14-fcbbee8beb29> ],
        [ ns1:value "Morphine sulfate is indicated for the relief of severe pain. The use of morphine for the relief of pain should be reserved for the more severe manifestations of pain, as in myocardial infarction,severe injuries, or in severe chronic pain associated with terminal cancer after all non-narcotic analgesics have failed." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e360d6b6-d9ef-487d-bf14-fcbbee8beb29> ],
        [ ns1:value "Morphine sulfate is indicated for the relief of severe pain. The use of morphine for the relief of pain should be reserved for the more severe manifestations of pain, as in myocardial infarction,severe injuries, or in severe chronic pain associated with terminal cancer after all non-narcotic analgesics have failed." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e360d6b6-d9ef-487d-bf14-fcbbee8beb29> ],
        <http://purl.org/np/RAIQbr-yR94NBPmMjym9ryVz2yrRE9IeIaAS7WHr6WN5Q#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00295> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAIQbr-yR94NBPmMjym9ryVz2yrRE9IeIaAS7WHr6WN5Q#quote> ns1:value "Morphine sulfate is indicated for the relief of severe pain. The use of morphine for the relief of pain should be reserved for the more severe manifestations of pain, as in myocardial infarction,severe injuries, or in severe chronic pain associated with terminal cancer after all non-narcotic analgesics have failed." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e360d6b6-d9ef-487d-bf14-fcbbee8beb29> .

<http://purl.org/np/RAJlzWs6I2Pzw-lHS6WCBBWIeymT_SOFhY5dvRa9zqfPM#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Alprazolam extended-release tablets are indicated for the treatment of panic disorder, with or without agoraphobia." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=79619e0f-1600-40ea-e053-2a91aa0a2700> ],
        <http://purl.org/np/RAJlzWs6I2Pzw-lHS6WCBBWIeymT_SOFhY5dvRa9zqfPM#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00404> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAJlzWs6I2Pzw-lHS6WCBBWIeymT_SOFhY5dvRa9zqfPM#quote> ns1:value "Alprazolam extended-release tablets are indicated for the treatment of panic disorder, with or without agoraphobia." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=79619e0f-1600-40ea-e053-2a91aa0a2700> .

<http://purl.org/np/RAJoCWIddRpNJwjYWs4ADKWFVqesZUDkYhZQq1d4Q5DsM#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Endogenous depression is more likely to be alleviated than are other depressive states." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94e984da-3b08-406f-8c10-e78844fca1ff> ],
        <http://purl.org/np/RAJoCWIddRpNJwjYWs4ADKWFVqesZUDkYhZQq1d4Q5DsM#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00321> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAJoCWIddRpNJwjYWs4ADKWFVqesZUDkYhZQq1d4Q5DsM#quote> ns1:value "Endogenous depression is more likely to be alleviated than are other depressive states." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94e984da-3b08-406f-8c10-e78844fca1ff> .

<http://purl.org/np/RAKSaOqvvlhH-AzyFzHhzYzINCheKAYF1NOm6vhpyC6FQ#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "temporarily relieves minor aches and pains due to:•the common cold•headache•backache•minor pain of arthritis•toothache•muscular aches•premenstrual and menstrual cramps•temporarily reduces fever" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f7cca9d-4230-49d7-b805-a1fbc73e31c9> ],
        <http://purl.org/np/RAKSaOqvvlhH-AzyFzHhzYzINCheKAYF1NOm6vhpyC6FQ#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00316> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAKSaOqvvlhH-AzyFzHhzYzINCheKAYF1NOm6vhpyC6FQ#quote> ns1:value "temporarily relieves minor aches and pains due to:•the common cold•headache•backache•minor pain of arthritis•toothache•muscular aches•premenstrual and menstrual cramps•temporarily reduces fever" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f7cca9d-4230-49d7-b805-a1fbc73e31c9> .

<http://purl.org/np/RAKcLCXliAoGMctRyClbxGwKs-qtqDJHN916bxoXuhhVg#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Divalproex sodium delayed-release capsules are indicated as monotherapy and adjunctive therapy in the treatment of adult patients and pediatric patients down to the age of 10 years with complex partial seizures that occur either in isolation or in association with other types of seizures." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f911748c-fb3a-fe1a-ab2a-4b40455e05ef> ],
        <http://purl.org/np/RAKcLCXliAoGMctRyClbxGwKs-qtqDJHN916bxoXuhhVg#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00313> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAKcLCXliAoGMctRyClbxGwKs-qtqDJHN916bxoXuhhVg#quote> ns1:value "Divalproex sodium delayed-release capsules are indicated as monotherapy and adjunctive therapy in the treatment of adult patients and pediatric patients down to the age of 10 years with complex partial seizures that occur either in isolation or in association with other types of seizures." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f911748c-fb3a-fe1a-ab2a-4b40455e05ef> .

<http://purl.org/np/RAL6P8CIyE3RSB83OAqPrVo_808Fe87mXqLaG5IQeVqcg#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebe34db4-816d-4f0a-adbb-826693662754> ],
        <http://purl.org/np/RAL6P8CIyE3RSB83OAqPrVo_808Fe87mXqLaG5IQeVqcg#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00230> ;
    ns2:targetPopulation <http://purl.org/np/RAL6P8CIyE3RSB83OAqPrVo_808Fe87mXqLaG5IQeVqcg#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAL6P8CIyE3RSB83OAqPrVo_808Fe87mXqLaG5IQeVqcg#quote> ns1:value "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebe34db4-816d-4f0a-adbb-826693662754> .

<http://purl.org/np/RAL6P8CIyE3RSB83OAqPrVo_808Fe87mXqLaG5IQeVqcg#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "patients 1 month of age and older" ;
    ns2:requiredMinAge "0" .

<http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Oxcarbazepine oral suspension is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2515391e-3a88-4226-92e5-f641c8409fe5> ],
        <http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00776> ;
    ns2:targetPopulation <http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#quote> ns1:value "Oxcarbazepine oral suspension is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2515391e-3a88-4226-92e5-f641c8409fe5> .

<http://purl.org/np/RALZwlL1TqgP-xvdQv-A6cEyBPxlpE8n1f6MlYHBIhP_o#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "pediatric patients aged 4 years and above" ;
    ns2:requiredMinAge "4" .

<http://purl.org/np/RALa6tOiCWAvRoo_pwjRkAY8w5hwxp5ZCUuqAZzWh0N5g#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscoskeletal Pain" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea2dc1a6-22d5-4295-9d39-9bf015dc5a89> ],
        <http://purl.org/np/RALa6tOiCWAvRoo_pwjRkAY8w5hwxp5ZCUuqAZzWh0N5g#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00476> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RALa6tOiCWAvRoo_pwjRkAY8w5hwxp5ZCUuqAZzWh0N5g#quote> ns1:value "Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscoskeletal Pain" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea2dc1a6-22d5-4295-9d39-9bf015dc5a89> .

<http://purl.org/np/RAMBLDIneLdqSDF5Ppb0vKyqYKs2ecJHgvwZcpOBq7n88#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bed3c03f4-2829-423f-a595-dc09c9cc0e40> ],
        <http://purl.org/np/RAMBLDIneLdqSDF5Ppb0vKyqYKs2ecJHgvwZcpOBq7n88#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01576> ;
    ns2:targetPopulation <http://purl.org/np/RAMBLDIneLdqSDF5Ppb0vKyqYKs2ecJHgvwZcpOBq7n88#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAMBLDIneLdqSDF5Ppb0vKyqYKs2ecJHgvwZcpOBq7n88#quote> ns1:value "Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bed3c03f4-2829-423f-a595-dc09c9cc0e40> .

<http://purl.org/np/RAMBLDIneLdqSDF5Ppb0vKyqYKs2ecJHgvwZcpOBq7n88#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "pediatric patients (ages 3 years to 16 years)" ;
    ns2:requiredMaxAge "16" ;
    ns2:requiredMinAge "3" .

<http://purl.org/np/RAMZo-qIoOhYneUeyQ8OGTQTeDwQTskjj0pSIw7S8ONKk#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1bf8b35a-b769-465c-a2f8-099868dfcd2f> ],
        <http://purl.org/np/RAMZo-qIoOhYneUeyQ8OGTQTeDwQTskjj0pSIw7S8ONKk#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00921> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAMZo-qIoOhYneUeyQ8OGTQTeDwQTskjj0pSIw7S8ONKk#quote> ns1:value "Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1bf8b35a-b769-465c-a2f8-099868dfcd2f> .

<http://purl.org/np/RAMvZYSyMNtfy1PH7IEAPNnp2eLsn63Hy-8_DBq0SDUgk#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Paroxetine tablets are indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-IV" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> ],
        <http://purl.org/np/RAMvZYSyMNtfy1PH7IEAPNnp2eLsn63Hy-8_DBq0SDUgk#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00715> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAMvZYSyMNtfy1PH7IEAPNnp2eLsn63Hy-8_DBq0SDUgk#quote> ns1:value "Paroxetine tablets are indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-IV" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> .

<http://purl.org/np/RANFBhYZ_fPuI8_E0zWdSw35hu3sxsCMpWj2pV2dY1ntU#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Ramelteon tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a89dae05-6c39-4072-b8ee-c4c35b46f7d4> ],
        <http://purl.org/np/RANFBhYZ_fPuI8_E0zWdSw35hu3sxsCMpWj2pV2dY1ntU#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00980> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RANFBhYZ_fPuI8_E0zWdSw35hu3sxsCMpWj2pV2dY1ntU#quote> ns1:value "Ramelteon tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a89dae05-6c39-4072-b8ee-c4c35b46f7d4> .

<http://purl.org/np/RANL2PUfRN6-Ps9oO3AVs2NuyWjccP8yPINMnwRbCtUzY#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Lamotrigine tablets are indicated for conversion to monotherapy in adults (aged 16 years and older) with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (AED)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> ],
        <http://purl.org/np/RANL2PUfRN6-Ps9oO3AVs2NuyWjccP8yPINMnwRbCtUzY#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00555> ;
    ns2:targetPopulation <http://purl.org/np/RANL2PUfRN6-Ps9oO3AVs2NuyWjccP8yPINMnwRbCtUzY#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RANL2PUfRN6-Ps9oO3AVs2NuyWjccP8yPINMnwRbCtUzY#quote> ns1:value "Lamotrigine tablets are indicated for conversion to monotherapy in adults (aged 16 years and older) with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (AED)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> .

<http://purl.org/np/RANL2PUfRN6-Ps9oO3AVs2NuyWjccP8yPINMnwRbCtUzY#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults (aged 16 years and older)" ;
    ns2:requiredMinAge "16" .

<http://purl.org/np/RANP4fACL3Mm4Kg4Bj8ykf-WWSl8czJV2I_gqnFP6txbQ#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Sertraline Tablets, USP are indicated for the treatment of major depressive disorder in adults." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> ],
        <http://purl.org/np/RANP4fACL3Mm4Kg4Bj8ykf-WWSl8czJV2I_gqnFP6txbQ#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB08567> ;
    ns2:targetPopulation <http://purl.org/np/RANP4fACL3Mm4Kg4Bj8ykf-WWSl8czJV2I_gqnFP6txbQ#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RANP4fACL3Mm4Kg4Bj8ykf-WWSl8czJV2I_gqnFP6txbQ#quote> ns1:value "Sertraline Tablets, USP are indicated for the treatment of major depressive disorder in adults." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> .

<http://purl.org/np/RANP4fACL3Mm4Kg4Bj8ykf-WWSl8czJV2I_gqnFP6txbQ#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAOjFmtAh1s_ZkjDjf-7ZhHG2VPILfv_NjcEg1OoyWfsY#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clonazepam is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-IV" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> ],
        <http://purl.org/np/RAOjFmtAh1s_ZkjDjf-7ZhHG2VPILfv_NjcEg1OoyWfsY#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01068> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAOjFmtAh1s_ZkjDjf-7ZhHG2VPILfv_NjcEg1OoyWfsY#quote> ns1:value "Clonazepam is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-IV" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> .

<http://purl.org/np/RAOxMuO5TN2MfPl8sTi9Flns8Hpfiak7nnW2tEAWrF1GM#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fosphenytoin sodium injection is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> ],
        <http://purl.org/np/RAOxMuO5TN2MfPl8sTi9Flns8Hpfiak7nnW2tEAWrF1GM#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01320> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAOxMuO5TN2MfPl8sTi9Flns8Hpfiak7nnW2tEAWrF1GM#quote> ns1:value "Fosphenytoin sodium injection is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> .

<http://purl.org/np/RAP-jD7XFEwMmtVSvvn286ZkMh_SkQ5NTeH5GCeRESMII#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Phenelzine Sulfate Tablets, USP has been found to be effective in depressed patients clinically characterized as \"atypical,\" \"nonendogenous,\" or \"neurotic.\"" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40483372-448f-4284-976c-8462ef256661> ],
        <http://purl.org/np/RAP-jD7XFEwMmtVSvvn286ZkMh_SkQ5NTeH5GCeRESMII#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00780> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAP-jD7XFEwMmtVSvvn286ZkMh_SkQ5NTeH5GCeRESMII#quote> ns1:value "Phenelzine Sulfate Tablets, USP has been found to be effective in depressed patients clinically characterized as \"atypical,\" \"nonendogenous,\" or \"neurotic.\"" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40483372-448f-4284-976c-8462ef256661> .

<http://purl.org/np/RAP12f5lS-xIlOhUN_1TfUXr_rD6zV0yaIL5WA6OVZsVw#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "For temporary relief of symptoms related to sleep disorders, Seasonal Affective Disorder, jet lag, and depression." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fdaf86c2-137d-4926-a63b-9faf7ec7e04c> ],
        <http://purl.org/np/RAP12f5lS-xIlOhUN_1TfUXr_rD6zV0yaIL5WA6OVZsVw#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01065> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAP12f5lS-xIlOhUN_1TfUXr_rD6zV0yaIL5WA6OVZsVw#quote> ns1:value "For temporary relief of symptoms related to sleep disorders, Seasonal Affective Disorder, jet lag, and depression." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fdaf86c2-137d-4926-a63b-9faf7ec7e04c> .

<http://purl.org/np/RAPVRrJwOjMqct306AM_HYIxMOt37ldLa2OHwHtbTjdhE#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Topiramate tablets and topiramate capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b> ],
        <http://purl.org/np/RAPVRrJwOjMqct306AM_HYIxMOt37ldLa2OHwHtbTjdhE#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00273> ;
    ns2:targetPopulation <http://purl.org/np/RAPVRrJwOjMqct306AM_HYIxMOt37ldLa2OHwHtbTjdhE#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAPVRrJwOjMqct306AM_HYIxMOt37ldLa2OHwHtbTjdhE#quote> ns1:value "Topiramate tablets and topiramate capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b> .

<http://purl.org/np/RAPVRrJwOjMqct306AM_HYIxMOt37ldLa2OHwHtbTjdhE#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "patients 2 years of age and older" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_1826> ;
    ns2:requiredMinAge "2" .

<http://purl.org/np/RAPtJoTJ2wBfxa0KCSi-uvOtJN5GpjFOBDDWJmUmSZ16U#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Paroxetine tablets are indicated for the treatment of social anxiety disorder, also known as social phobia, as defined in DSM-IV (300.23)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> ],
        <http://purl.org/np/RAPtJoTJ2wBfxa0KCSi-uvOtJN5GpjFOBDDWJmUmSZ16U#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00715> ;
    ns2:targetPopulation <http://purl.org/np/RAPtJoTJ2wBfxa0KCSi-uvOtJN5GpjFOBDDWJmUmSZ16U#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAPtJoTJ2wBfxa0KCSi-uvOtJN5GpjFOBDDWJmUmSZ16U#quote> ns1:value "Paroxetine tablets are indicated for the treatment of social anxiety disorder, also known as social phobia, as defined in DSM-IV (300.23)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> .

<http://purl.org/np/RAPtJoTJ2wBfxa0KCSi-uvOtJN5GpjFOBDDWJmUmSZ16U#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult patients" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RARIsITXB4P5uL2XBy6jxw8M-KSWCuPsYpe8fXXiV4Sd8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Pimozide Tablets, USP is indicated for the suppression of motor and phonic tics in patients with Tourette’s Disorder who have failed to respond satisfactorily to standard treatment." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=70b079e2-a1f7-4a93-8685-d60a4d7c1280> ],
        <http://purl.org/np/RARIsITXB4P5uL2XBy6jxw8M-KSWCuPsYpe8fXXiV4Sd8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01100> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RARIsITXB4P5uL2XBy6jxw8M-KSWCuPsYpe8fXXiV4Sd8#quote> ns1:value "Pimozide Tablets, USP is indicated for the suppression of motor and phonic tics in patients with Tourette’s Disorder who have failed to respond satisfactorily to standard treatment." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=70b079e2-a1f7-4a93-8685-d60a4d7c1280> .

<http://purl.org/np/RARZxdx5w8R_LaJHHGxT64nvFHVwrQdHnn4CH07QBEZmI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of the syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or not be warranted." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d40847-e0d3-48ec-81a7-ec5478553565> ],
        <http://purl.org/np/RARZxdx5w8R_LaJHHGxT64nvFHVwrQdHnn4CH07QBEZmI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00182> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RARZxdx5w8R_LaJHHGxT64nvFHVwrQdHnn4CH07QBEZmI#quote> ns1:value "Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. The diagnosis of the syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or not be warranted." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53d40847-e0d3-48ec-81a7-ec5478553565> .

<http://purl.org/np/RARyMK72tz-EMY27igrIvPbdvypnPR-SaDfb7ZIR1jFuA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Celecoxib capsules are indicated [...] For the management of acute pain in adults" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27d813ea-7798-09cb-734b-b970d7248f1f> ],
        <http://purl.org/np/RARyMK72tz-EMY27igrIvPbdvypnPR-SaDfb7ZIR1jFuA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00482> ;
    ns2:targetPopulation <http://purl.org/np/RARyMK72tz-EMY27igrIvPbdvypnPR-SaDfb7ZIR1jFuA#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RARyMK72tz-EMY27igrIvPbdvypnPR-SaDfb7ZIR1jFuA#quote> ns1:value "Celecoxib capsules are indicated [...] For the management of acute pain in adults" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27d813ea-7798-09cb-734b-b970d7248f1f> .

<http://purl.org/np/RARyMK72tz-EMY27igrIvPbdvypnPR-SaDfb7ZIR1jFuA#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RASAH0yTnb2F3fYzixv9AxVI5MZPDSM9hLE55K0zOyXZI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older:  partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> ],
        <http://purl.org/np/RASAH0yTnb2F3fYzixv9AxVI5MZPDSM9hLE55K0zOyXZI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00555> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RASAH0yTnb2F3fYzixv9AxVI5MZPDSM9hLE55K0zOyXZI#quote> ns1:value "Lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older:  partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> .

<http://purl.org/np/RASX99d9pr79inB-QYzelBosH3vJq3yXmCNTM2CWdeCB4#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RASX99d9pr79inB-QYzelBosH3vJq3yXmCNTM2CWdeCB4#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RASX99d9pr79inB-QYzelBosH3vJq3yXmCNTM2CWdeCB4#quote> ns1:value "In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RAS__Y0u2wSFDLM4FcTwWhBg5EOe-3aqclkPEgmWSH4jA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Phenelzine Sulfate Tablets, USP has been found to be effective in depressed patients clinically characterized as \"atypical,\" \"nonendogenous,\" or \"neurotic.\"" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40483372-448f-4284-976c-8462ef256661> ],
        <http://purl.org/np/RAS__Y0u2wSFDLM4FcTwWhBg5EOe-3aqclkPEgmWSH4jA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00780> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAS__Y0u2wSFDLM4FcTwWhBg5EOe-3aqclkPEgmWSH4jA#quote> ns1:value "Phenelzine Sulfate Tablets, USP has been found to be effective in depressed patients clinically characterized as \"atypical,\" \"nonendogenous,\" or \"neurotic.\"" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40483372-448f-4284-976c-8462ef256661> .

<http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Vigabatrin for oral solution is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b8fb137-848b-45fd-9107-a6db5a675360> ],
        <http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01080> ;
    ns2:targetPopulation <http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#quote> ns1:value "Vigabatrin for oral solution is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b8fb137-848b-45fd-9107-a6db5a675360> .

<http://purl.org/np/RATgYbpNYnktiU1M5OCbD8mT1KGMYTl3GtUUZ_9HMdPOg#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "pediatric patients with infantile spasms 1 month to 2 years of age" ;
    ns2:requiredMaxAge "2" ;
    ns2:requiredMinAge "0" .

<http://purl.org/np/RATi0q3mcdhzdBIPpLDVsHBiPDH7NjqJC8g1-PDBc6sUQ#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Sertraline tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (OCD), as defined in the DSM-III-R; i.e., the obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> ],
        <http://purl.org/np/RATi0q3mcdhzdBIPpLDVsHBiPDH7NjqJC8g1-PDBc6sUQ#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB08567> ;
    ns2:targetPopulation <http://purl.org/np/RATi0q3mcdhzdBIPpLDVsHBiPDH7NjqJC8g1-PDBc6sUQ#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RATi0q3mcdhzdBIPpLDVsHBiPDH7NjqJC8g1-PDBc6sUQ#quote> ns1:value "Sertraline tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (OCD), as defined in the DSM-III-R; i.e., the obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> .

<http://purl.org/np/RATi0q3mcdhzdBIPpLDVsHBiPDH7NjqJC8g1-PDBc6sUQ#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RATxISZAhIHtOdOcObiF3psNaG4KvkUOpWgAhAMtY7VeU#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clobazam tablet is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=721dde68-db83-4dad-8649-8046cb455372> ],
        <http://purl.org/np/RATxISZAhIHtOdOcObiF3psNaG4KvkUOpWgAhAMtY7VeU#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00349> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RATxISZAhIHtOdOcObiF3psNaG4KvkUOpWgAhAMtY7VeU#quote> ns1:value "Clobazam tablet is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=721dde68-db83-4dad-8649-8046cb455372> .

<http://purl.org/np/RAUUK3nf5YbAO_uPlkOliVDJo3m-JnTMxa7qu9TWZQZ18#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Vyvanse® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a310fc51-2743-4755-8398-fed5402283f6> ],
        <http://purl.org/np/RAUUK3nf5YbAO_uPlkOliVDJo3m-JnTMxa7qu9TWZQZ18#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01255> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAUUK3nf5YbAO_uPlkOliVDJo3m-JnTMxa7qu9TWZQZ18#quote> ns1:value "Vyvanse® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a310fc51-2743-4755-8398-fed5402283f6> .

<http://purl.org/np/RAVEw_yFWhB_mycDe0UNnldtUAVssPKoJ15i7dHWoJMa0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> ],
        <http://purl.org/np/RAVEw_yFWhB_mycDe0UNnldtUAVssPKoJ15i7dHWoJMa0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00555> ;
    ns3:indicationType ns2:PreventionIndication .

<http://purl.org/np/RAVEw_yFWhB_mycDe0UNnldtUAVssPKoJ15i7dHWoJMa0#quote> ns1:value "Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> .

<http://purl.org/np/RAVnbvtQSRA3gN-YCc5RDoJfwRU8yUvr_3ll0f3TQODf0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RAVnbvtQSRA3gN-YCc5RDoJfwRU8yUvr_3ll0f3TQODf0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAVnbvtQSRA3gN-YCc5RDoJfwRU8yUvr_3ll0f3TQODf0#quote> ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RAXC5X6BalHUIKv3Mu8MDuqaa_Ctr2rya5Lcm3U0DwxVI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Aripiprazole oral solution is indicated for the treatment of: acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f272100-e02f-4a16-bb39-a2bf844db4f9> ],
        <http://purl.org/np/RAXC5X6BalHUIKv3Mu8MDuqaa_Ctr2rya5Lcm3U0DwxVI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01238> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAXC5X6BalHUIKv3Mu8MDuqaa_Ctr2rya5Lcm3U0DwxVI#quote> ns1:value "Aripiprazole oral solution is indicated for the treatment of: acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f272100-e02f-4a16-bb39-a2bf844db4f9> .

<http://purl.org/np/RAXlqX4ddS9FHfHYeBimA9MJcOGwT9ewT4srEZMnIvWSg#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Tramadol hydrochloride tablets are indicated for the management of moderate to moderately severe pain in adults" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7c54b1-b440-4cca-97e8-e5b825413d32> ],
        <http://purl.org/np/RAXlqX4ddS9FHfHYeBimA9MJcOGwT9ewT4srEZMnIvWSg#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00193> ;
    ns2:targetPopulation <http://purl.org/np/RAXlqX4ddS9FHfHYeBimA9MJcOGwT9ewT4srEZMnIvWSg#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAXlqX4ddS9FHfHYeBimA9MJcOGwT9ewT4srEZMnIvWSg#quote> ns1:value "Tramadol hydrochloride tablets are indicated for the management of moderate to moderately severe pain in adults" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7c54b1-b440-4cca-97e8-e5b825413d32> .

<http://purl.org/np/RAXlqX4ddS9FHfHYeBimA9MJcOGwT9ewT4srEZMnIvWSg#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAXv-RjzkkyXPSfQVP06bHElhavrn8HJsiQPYmjNQddjA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Topiramate tablets and topiramate capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b> ],
        <http://purl.org/np/RAXv-RjzkkyXPSfQVP06bHElhavrn8HJsiQPYmjNQddjA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00273> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAXv-RjzkkyXPSfQVP06bHElhavrn8HJsiQPYmjNQddjA#quote> ns1:value "Topiramate tablets and topiramate capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b> .

<http://purl.org/np/RAYvT2opGh-4_7tLm8LPGT-hEbPPo14_agjHaYcZee66c#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RAYvT2opGh-4_7tLm8LPGT-hEbPPo14_agjHaYcZee66c#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAYvT2opGh-4_7tLm8LPGT-hEbPPo14_agjHaYcZee66c#quote> ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RAZ31mwyrGNeOAlzXZWCkfxmUXwwMUqRDkiBrdwFqABRw#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Venlafaxine tablets, USP are indicated for the treatment of major depressive disorder." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b23637e5-d37f-41b5-ba76-fc053e903bc2> ],
        <http://purl.org/np/RAZ31mwyrGNeOAlzXZWCkfxmUXwwMUqRDkiBrdwFqABRw#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00285> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAZ31mwyrGNeOAlzXZWCkfxmUXwwMUqRDkiBrdwFqABRw#quote> ns1:value "Venlafaxine tablets, USP are indicated for the treatment of major depressive disorder." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b23637e5-d37f-41b5-ba76-fc053e903bc2> .

<http://purl.org/np/RAZD0J6i7HXVATsy1HYgDs3QlLICLxUAA2j2wffAphNv8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Risperidone tablets are indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in Adults" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> ],
        [ ns1:value "Risperidone tablets are indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in Adults" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> ],
        <http://purl.org/np/RAZD0J6i7HXVATsy1HYgDs3QlLICLxUAA2j2wffAphNv8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00734> ;
    ns2:targetPopulation <http://purl.org/np/RAZD0J6i7HXVATsy1HYgDs3QlLICLxUAA2j2wffAphNv8#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAZD0J6i7HXVATsy1HYgDs3QlLICLxUAA2j2wffAphNv8#quote> ns1:value "Risperidone tablets are indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in Adults" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> .

<http://purl.org/np/RAZD0J6i7HXVATsy1HYgDs3QlLICLxUAA2j2wffAphNv8#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "Adults",
        "adults" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_14042> ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAZM3lGBHEj1hzRcGBNp7FhB7FBKk7crUEyUTTCDv5fBo#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Mirtazapine tablets, USP are indicated for the treatment of major depressive disorder." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0039f505-7cd0-4d79-b5dd-bf2d172571a0> ],
        <http://purl.org/np/RAZM3lGBHEj1hzRcGBNp7FhB7FBKk7crUEyUTTCDv5fBo#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00370> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAZM3lGBHEj1hzRcGBNp7FhB7FBKk7crUEyUTTCDv5fBo#quote> ns1:value "Mirtazapine tablets, USP are indicated for the treatment of major depressive disorder." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0039f505-7cd0-4d79-b5dd-bf2d172571a0> .

<http://purl.org/np/RAZW8rLrF4eNXyUjFi5-p_RCY65f2Uq13458Nj2spZNgQ#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b8fb137-848b-45fd-9107-a6db5a675360> ],
        <http://purl.org/np/RAZW8rLrF4eNXyUjFi5-p_RCY65f2Uq13458Nj2spZNgQ#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01080> ;
    ns2:targetPopulation <http://purl.org/np/RAZW8rLrF4eNXyUjFi5-p_RCY65f2Uq13458Nj2spZNgQ#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAZW8rLrF4eNXyUjFi5-p_RCY65f2Uq13458Nj2spZNgQ#quote> ns1:value "Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b8fb137-848b-45fd-9107-a6db5a675360> .

<http://purl.org/np/RAZW8rLrF4eNXyUjFi5-p_RCY65f2Uq13458Nj2spZNgQ#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults and pediatric patients 2 years of age and older" ;
    ns2:requiredMinAge "2" .

<http://purl.org/np/RA_0ay3tAx_-uDcvwHRRkPxR78Ezvs-1sw5a3lluXUCxA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD)" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> ],
        <http://purl.org/np/RA_0ay3tAx_-uDcvwHRRkPxR78Ezvs-1sw5a3lluXUCxA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00472> ;
    ns2:targetPopulation <http://purl.org/np/RA_0ay3tAx_-uDcvwHRRkPxR78Ezvs-1sw5a3lluXUCxA#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA_0ay3tAx_-uDcvwHRRkPxR78Ezvs-1sw5a3lluXUCxA#quote> ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD)" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> .

<http://purl.org/np/RA_0ay3tAx_-uDcvwHRRkPxR78Ezvs-1sw5a3lluXUCxA#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult and paediatric patients" ;
    ns2:requiredMinAge "7" .

<http://purl.org/np/RA_b4CBVFPDfQXNn4W-bKnkOLksphW_tWhaHxzwfEEww4#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Topiramate tablets and topiramate capsules are indicated for the preventive treatment of migraine in patients 12 years of age and older" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b> ],
        <http://purl.org/np/RA_b4CBVFPDfQXNn4W-bKnkOLksphW_tWhaHxzwfEEww4#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00273> ;
    ns2:targetPopulation <http://purl.org/np/RA_b4CBVFPDfQXNn4W-bKnkOLksphW_tWhaHxzwfEEww4#targetpop> ;
    ns3:indicationType ns2:PreventionIndication .

<http://purl.org/np/RA_b4CBVFPDfQXNn4W-bKnkOLksphW_tWhaHxzwfEEww4#quote> ns1:value "Topiramate tablets and topiramate capsules are indicated for the preventive treatment of migraine in patients 12 years of age and older" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b> .

<http://purl.org/np/RA_b4CBVFPDfQXNn4W-bKnkOLksphW_tWhaHxzwfEEww4#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "patients 12 years of age and older" ;
    ns2:requiredMinAge "12" .

<http://purl.org/np/RA_pMhpmS3t3JwsrNixJvQZtEq0YOIKgIstTcgmw30Cuk#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RA_pMhpmS3t3JwsrNixJvQZtEq0YOIKgIstTcgmw30Cuk#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA_pMhpmS3t3JwsrNixJvQZtEq0YOIKgIstTcgmw30Cuk#quote> ns1:value "In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RA_yy84QQBDGT7sMF22SuryjW56nraTqqmJB_Whhiql4Y#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "AMRIX® (cyclobenzaprine hydrochloride extended-release capsules) is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.  [...] Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3902123b-1365-ac3c-0934-afff9eeeb1bd> ],
        <http://purl.org/np/RA_yy84QQBDGT7sMF22SuryjW56nraTqqmJB_Whhiql4Y#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00924> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RA_yy84QQBDGT7sMF22SuryjW56nraTqqmJB_Whhiql4Y#quote> ns1:value "AMRIX® (cyclobenzaprine hydrochloride extended-release capsules) is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.  [...] Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3902123b-1365-ac3c-0934-afff9eeeb1bd> .

<http://purl.org/np/RAaTX5aHox7tzzPG9AMdX1SYvVVLT0O0UMTXQNgpHaWyA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Methylphenidate Hydrochloride is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2cf1b26b-199d-4c7f-ab64-4805a9def2cc> ],
        <http://purl.org/np/RAaTX5aHox7tzzPG9AMdX1SYvVVLT0O0UMTXQNgpHaWyA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00422> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAaTX5aHox7tzzPG9AMdX1SYvVVLT0O0UMTXQNgpHaWyA#quote> ns1:value "Methylphenidate Hydrochloride is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2cf1b26b-199d-4c7f-ab64-4805a9def2cc> .

<http://purl.org/np/RAbUzIDUfwVgV6tveJX5PFTA9O7bDdO2cr8gfeXW8B_u4#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Risperidone tablets are indicated for the acute and maintenance treatment of schizophrenia" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> ],
        <http://purl.org/np/RAbUzIDUfwVgV6tveJX5PFTA9O7bDdO2cr8gfeXW8B_u4#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00734> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAbUzIDUfwVgV6tveJX5PFTA9O7bDdO2cr8gfeXW8B_u4#quote> ns1:value "Risperidone tablets are indicated for the acute and maintenance treatment of schizophrenia" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> .

<http://purl.org/np/RAbzl9aPdve5RHvCzOfardZ8LdZU2I2iIqYBCJg9c7Gpc#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older: partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> ],
        <http://purl.org/np/RAbzl9aPdve5RHvCzOfardZ8LdZU2I2iIqYBCJg9c7Gpc#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00555> ;
    ns2:targetPopulation <http://purl.org/np/RAbzl9aPdve5RHvCzOfardZ8LdZU2I2iIqYBCJg9c7Gpc#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAbzl9aPdve5RHvCzOfardZ8LdZU2I2iIqYBCJg9c7Gpc#quote> ns1:value "Lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older: partial-onset seizures. primary generalized tonic-clonic (PGTC) seizures. generalized seizures of Lennox-Gastaut syndrome." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> .

<http://purl.org/np/RAbzl9aPdve5RHvCzOfardZ8LdZU2I2iIqYBCJg9c7Gpc#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "patients aged 2 years and older" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_1826> ;
    ns2:requiredMinAge "2" .

<http://purl.org/np/RAcRBXfdJ72S0buCh-nka-5L3GgJbA5lHbwbbvc1yhPcw#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Paroxetine tablets are indicated for the treatment of Generalized Anxiety Disorder (GAD), as defined in DSM-IV. The efficacy of paroxetine tablets in the treatment of GAD was established in two 8-week placebo-controlled trials in adults with GAD. Paroxetine tablets have not been studied in children or adolescents with Generalized Anxiety Disorder" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> ],
        <http://purl.org/np/RAcRBXfdJ72S0buCh-nka-5L3GgJbA5lHbwbbvc1yhPcw#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00715> ;
    ns2:targetPopulation <http://purl.org/np/RAcRBXfdJ72S0buCh-nka-5L3GgJbA5lHbwbbvc1yhPcw#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAcRBXfdJ72S0buCh-nka-5L3GgJbA5lHbwbbvc1yhPcw#quote> ns1:value "Paroxetine tablets are indicated for the treatment of Generalized Anxiety Disorder (GAD), as defined in DSM-IV. The efficacy of paroxetine tablets in the treatment of GAD was established in two 8-week placebo-controlled trials in adults with GAD. Paroxetine tablets have not been studied in children or adolescents with Generalized Anxiety Disorder" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> .

<http://purl.org/np/RAcRBXfdJ72S0buCh-nka-5L3GgJbA5lHbwbbvc1yhPcw#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAcpGnsTznjYKeF2ESL6VwTAZuTmf3pdbDcl3Sf9l_SMo#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33999f17-f689-40a1-955a-fb19c0590e0e> ],
        <http://purl.org/np/RAcpGnsTznjYKeF2ESL6VwTAZuTmf3pdbDcl3Sf9l_SMo#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00490> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAcpGnsTznjYKeF2ESL6VwTAZuTmf3pdbDcl3Sf9l_SMo#quote> ns1:value "Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33999f17-f689-40a1-955a-fb19c0590e0e> .

<http://purl.org/np/RAdA4fRU2LJMyBlcrde2uTxo7Xwoi23SAHXbRLboIvZTk#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Bupropion hydrochloride extended-release tablets (XL) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f32a4532-7dfd-4aa5-bb48-afbbd2eefb7c> ],
        <http://purl.org/np/RAdA4fRU2LJMyBlcrde2uTxo7Xwoi23SAHXbRLboIvZTk#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01156> ;
    ns3:indicationType ns2:PreventionIndication .

<http://purl.org/np/RAdA4fRU2LJMyBlcrde2uTxo7Xwoi23SAHXbRLboIvZTk#quote> ns1:value "Bupropion hydrochloride extended-release tablets (XL) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f32a4532-7dfd-4aa5-bb48-afbbd2eefb7c> .

<http://purl.org/np/RAdQtrGuinuXuvRna6BEKb_V9aL81mrPIji-SgcIxiUF0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson’s disease." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4fe7106d-4bf6-4794-87cb-8df616994c41> ],
        <http://purl.org/np/RAdQtrGuinuXuvRna6BEKb_V9aL81mrPIji-SgcIxiUF0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00413> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAdQtrGuinuXuvRna6BEKb_V9aL81mrPIji-SgcIxiUF0#quote> ns1:value "Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson’s disease." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4fe7106d-4bf6-4794-87cb-8df616994c41> .

<http://purl.org/np/RAdTQIUPysHrwinGgjZBSWIPXr35YqudTX8L8LuolXhM4#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Aripiprazole oral solution is indicated for the treatment of: Irritability Associated with Autistic Disorder" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f272100-e02f-4a16-bb39-a2bf844db4f9> ],
        <http://purl.org/np/RAdTQIUPysHrwinGgjZBSWIPXr35YqudTX8L8LuolXhM4#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01238> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAdTQIUPysHrwinGgjZBSWIPXr35YqudTX8L8LuolXhM4#quote> ns1:value "Aripiprazole oral solution is indicated for the treatment of: Irritability Associated with Autistic Disorder" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f272100-e02f-4a16-bb39-a2bf844db4f9> .

<http://purl.org/np/RAdd2yLrhTMtrGoDA1ZVLZaThCJ4WYi5oQhAcC0hmjkn8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in thetreatment of partial onset seizures in adults with epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        <http://purl.org/np/RAdd2yLrhTMtrGoDA1ZVLZaThCJ4WYi5oQhAcC0hmjkn8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01202> ;
    ns2:targetPopulation <http://purl.org/np/RAdd2yLrhTMtrGoDA1ZVLZaThCJ4WYi5oQhAcC0hmjkn8#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAdd2yLrhTMtrGoDA1ZVLZaThCJ4WYi5oQhAcC0hmjkn8#quote> ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in thetreatment of partial onset seizures in adults with epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> .

<http://purl.org/np/RAdd2yLrhTMtrGoDA1ZVLZaThCJ4WYi5oQhAcC0hmjkn8#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult patients (16 years and older)" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_1826> ;
    ns2:requiredMinAge "16" .

<http://purl.org/np/RAeknHMktChyEjUGeoJko4GkBrrfX4ZjLDOSYXpVHUcX8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington's disease." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=471ac1d8-e3ad-7729-87c5-c26ae92c32eb> ],
        <http://purl.org/np/RAeknHMktChyEjUGeoJko4GkBrrfX4ZjLDOSYXpVHUcX8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB04844> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAeknHMktChyEjUGeoJko4GkBrrfX4ZjLDOSYXpVHUcX8#quote> ns1:value "Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington's disease." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=471ac1d8-e3ad-7729-87c5-c26ae92c32eb> .

<http://purl.org/np/RAep04jBh9mzQ8bRaPGmD6QpjuP0iYVef6_S3cm35bc-s#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bed3c03f4-2829-423f-a595-dc09c9cc0e40> ],
        <http://purl.org/np/RAep04jBh9mzQ8bRaPGmD6QpjuP0iYVef6_S3cm35bc-s#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01576> ;
    ns2:targetPopulation <http://purl.org/np/RAep04jBh9mzQ8bRaPGmD6QpjuP0iYVef6_S3cm35bc-s#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAep04jBh9mzQ8bRaPGmD6QpjuP0iYVef6_S3cm35bc-s#quote> ns1:value "Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bed3c03f4-2829-423f-a595-dc09c9cc0e40> .

<http://purl.org/np/RAep04jBh9mzQ8bRaPGmD6QpjuP0iYVef6_S3cm35bc-s#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "pediatric patients (ages 3 years to 16 years)" ;
    ns2:requiredMaxAge "16" ;
    ns2:requiredMinAge "3" .

<http://purl.org/np/RAf8wCmRfuGxxSK0BhsSLxgEOrGWdk-lIcGBy7_MgU67g#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Risperidone tablets are indicated for the acute and maintenance treatment of schizophrenia" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> ],
        <http://purl.org/np/RAf8wCmRfuGxxSK0BhsSLxgEOrGWdk-lIcGBy7_MgU67g#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00734> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAf8wCmRfuGxxSK0BhsSLxgEOrGWdk-lIcGBy7_MgU67g#quote> ns1:value "Risperidone tablets are indicated for the acute and maintenance treatment of schizophrenia" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> .

<http://purl.org/np/RAfWKLJ_YtuQUAiulnJtEiVDqaMsL1OCxIDcsqfBLqlf0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Escitalopram oral solution, USP is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c871d3fe-5ca2-410c-976d-9ec4b72c878f> ],
        <http://purl.org/np/RAfWKLJ_YtuQUAiulnJtEiVDqaMsL1OCxIDcsqfBLqlf0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01175> ;
    ns2:targetPopulation <http://purl.org/np/RAfWKLJ_YtuQUAiulnJtEiVDqaMsL1OCxIDcsqfBLqlf0#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAfWKLJ_YtuQUAiulnJtEiVDqaMsL1OCxIDcsqfBLqlf0#quote> ns1:value "Escitalopram oral solution, USP is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c871d3fe-5ca2-410c-976d-9ec4b72c878f> .

<http://purl.org/np/RAfWKLJ_YtuQUAiulnJtEiVDqaMsL1OCxIDcsqfBLqlf0#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults and in adolescents 12 to 17 years of age" ;
    ns2:requiredMinAge "12" .

<http://purl.org/np/RAg86crtDEhv7zKWrf8yRC4c8tkSn1J1XLQ8SsgObH3_o#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> ],
        <http://purl.org/np/RAg86crtDEhv7zKWrf8yRC4c8tkSn1J1XLQ8SsgObH3_o#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00555> ;
    ns3:indicationType ns2:PreventionIndication .

<http://purl.org/np/RAg86crtDEhv7zKWrf8yRC4c8tkSn1J1XLQ8SsgObH3_o#quote> ns1:value "Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> .

<http://purl.org/np/RAgaIIsnfQA7eiRx7Ndus9eUFuRlux2-L3CJkbAYDfcw4#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Risperidone tablets are indicated for the treatment of irritability associated with autistic disorder in children and adolescents aged 5-16 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> ],
        <http://purl.org/np/RAgaIIsnfQA7eiRx7Ndus9eUFuRlux2-L3CJkbAYDfcw4#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00734> ;
    ns2:targetPopulation <http://purl.org/np/RAgaIIsnfQA7eiRx7Ndus9eUFuRlux2-L3CJkbAYDfcw4#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAgaIIsnfQA7eiRx7Ndus9eUFuRlux2-L3CJkbAYDfcw4#quote> ns1:value "Risperidone tablets are indicated for the treatment of irritability associated with autistic disorder in children and adolescents aged 5-16 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0c3eeb6-8a75-0b20-2008-396e63cddcdb> .

<http://purl.org/np/RAgaIIsnfQA7eiRx7Ndus9eUFuRlux2-L3CJkbAYDfcw4#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "children and adolescents" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_12849> ;
    ns2:requiredMaxAge "16" ;
    ns2:requiredMinAge "5" .

<http://purl.org/np/RAhzeLbz6XHyBGj7cXxNgl-i47ongBoHptVGmth9x8Tb8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> ],
        <http://purl.org/np/RAhzeLbz6XHyBGj7cXxNgl-i47ongBoHptVGmth9x8Tb8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01068> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAhzeLbz6XHyBGj7cXxNgl-i47ongBoHptVGmth9x8Tb8#quote> ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> .

<http://purl.org/np/RAi6IZmGwMCIuMxSab0NUW4bfWtR3m91HewclLVWxXxSA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Ropinirole tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5ce07b9-ad0d-4b72-9daf-8662775af093> ],
        <http://purl.org/np/RAi6IZmGwMCIuMxSab0NUW4bfWtR3m91HewclLVWxXxSA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00268> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAi6IZmGwMCIuMxSab0NUW4bfWtR3m91HewclLVWxXxSA#quote> ns1:value "Ropinirole tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5ce07b9-ad0d-4b72-9daf-8662775af093> .

<http://purl.org/np/RAiFVJiWLwjb9S5XpQ3hw9HSX5sj5Ggn4VYN1RkxGBFa0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Citalopram tablets are indicated for the treatment of depression" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2632b547-2e13-447f-ac85-c774e437d6a8> ],
        <http://purl.org/np/RAiFVJiWLwjb9S5XpQ3hw9HSX5sj5Ggn4VYN1RkxGBFa0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00215> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAiFVJiWLwjb9S5XpQ3hw9HSX5sj5Ggn4VYN1RkxGBFa0#quote> ns1:value "Citalopram tablets are indicated for the treatment of depression" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2632b547-2e13-447f-ac85-c774e437d6a8> .

<http://purl.org/np/RAj8XJBzGFMRz7oBD98LvUd7lXD2_nEGhaXcKr1Fdckxs#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> ],
        <http://purl.org/np/RAj8XJBzGFMRz7oBD98LvUd7lXD2_nEGhaXcKr1Fdckxs#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00555> ;
    ns3:indicationType ns2:PreventionIndication .

<http://purl.org/np/RAj8XJBzGFMRz7oBD98LvUd7lXD2_nEGhaXcKr1Fdckxs#quote> ns1:value "Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b0f0209-edbd-46f3-9bed-762cbea0d737> .

<http://purl.org/np/RAjHiPctclLo02Y_fYTyDkpUinnxmFOfTqlEsgpfuMvCE#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RAjHiPctclLo02Y_fYTyDkpUinnxmFOfTqlEsgpfuMvCE#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAjHiPctclLo02Y_fYTyDkpUinnxmFOfTqlEsgpfuMvCE#quote> ns1:value "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RAjaVpcbWl5V3wThr9RfjXR-Y5nZMDVBsOF3oc_yN59Es#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Pyridostigmine Bromide Oral Solution, USP is useful in the treatment of myasthenia gravis." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ef78ff05-8e0f-463a-88cd-ca9a01aed76a> ],
        <http://purl.org/np/RAjaVpcbWl5V3wThr9RfjXR-Y5nZMDVBsOF3oc_yN59Es#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00545> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAjaVpcbWl5V3wThr9RfjXR-Y5nZMDVBsOF3oc_yN59Es#quote> ns1:value "Pyridostigmine Bromide Oral Solution, USP is useful in the treatment of myasthenia gravis." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ef78ff05-8e0f-463a-88cd-ca9a01aed76a> .

<http://purl.org/np/RAjjpJ8F8ak6gw_7kD3ST1jgH2Dh9U34RplBA9J6tNP3o#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e6bea44-57d6-4bac-9328-46e1ee59f83b> ],
        <http://purl.org/np/RAjjpJ8F8ak6gw_7kD3ST1jgH2Dh9U34RplBA9J6tNP3o#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB05316> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAjjpJ8F8ak6gw_7kD3ST1jgH2Dh9U34RplBA9J6tNP3o#quote> ns1:value "NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e6bea44-57d6-4bac-9328-46e1ee59f83b> .

<http://purl.org/np/RAl-2Jo0As-tdFyAexbYEfgnDPPq-PKxwvnRY6eoeGI5U#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Eszopiclone Tablets are indicated for the treatment of insomnia." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49f71eb4-15ca-42e2-b62b-7963cc8ef115> ],
        <http://purl.org/np/RAl-2Jo0As-tdFyAexbYEfgnDPPq-PKxwvnRY6eoeGI5U#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00402> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAl-2Jo0As-tdFyAexbYEfgnDPPq-PKxwvnRY6eoeGI5U#quote> ns1:value "Eszopiclone Tablets are indicated for the treatment of insomnia." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49f71eb4-15ca-42e2-b62b-7963cc8ef115> .

<http://purl.org/np/RAl4WREWS2kLIELieLL6y_fp0D7ZVwH-m2oSb-LzdhQnc#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Paroxetine tablets are indicated for the treatment of Posttraumatic Stress Disorder (PTSD). The efficacy of paroxetine tablets in the treatment of PTSD was established in two 12-week placebo-controlled trials in adults with PTSD" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> ],
        <http://purl.org/np/RAl4WREWS2kLIELieLL6y_fp0D7ZVwH-m2oSb-LzdhQnc#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00715> ;
    ns2:targetPopulation <http://purl.org/np/RAl4WREWS2kLIELieLL6y_fp0D7ZVwH-m2oSb-LzdhQnc#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAl4WREWS2kLIELieLL6y_fp0D7ZVwH-m2oSb-LzdhQnc#quote> ns1:value "Paroxetine tablets are indicated for the treatment of Posttraumatic Stress Disorder (PTSD). The efficacy of paroxetine tablets in the treatment of PTSD was established in two 12-week placebo-controlled trials in adults with PTSD" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> .

<http://purl.org/np/RAl4WREWS2kLIELieLL6y_fp0D7ZVwH-m2oSb-LzdhQnc#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAlOsJ35aCx0B-TZrbf0ldAI6pUXWdUiIuP3JjoZbO9bY#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92ca69d4-cdba-4789-91a9-922664d52498> ],
        <http://purl.org/np/RAlOsJ35aCx0B-TZrbf0ldAI6pUXWdUiIuP3JjoZbO9bY#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00458> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAlOsJ35aCx0B-TZrbf0ldAI6pUXWdUiIuP3JjoZbO9bY#quote> ns1:value "For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92ca69d4-cdba-4789-91a9-922664d52498> .

<http://purl.org/np/RAmhgfMT81pvxE-TD0vTNffPUmnheLfc5_MzUOHz582cI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Trihexyphenidyl is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6f08000-e973-4bab-810c-b69f6c8ee4f3> ],
        <http://purl.org/np/RAmhgfMT81pvxE-TD0vTNffPUmnheLfc5_MzUOHz582cI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00376> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAmhgfMT81pvxE-TD0vTNffPUmnheLfc5_MzUOHz582cI#quote> ns1:value "Trihexyphenidyl is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6f08000-e973-4bab-810c-b69f6c8ee4f3> .

<http://purl.org/np/RAmiiMVoIdWEWsLw9fFuXPJlGsE6dRhc4X9LvjdY4FbPo#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Treatment of adult and adolescent patients (13 to 17 years) with schizophrenia" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afad3051-9df2-4c54-9684-e8262a133af8> ],
        <http://purl.org/np/RAmiiMVoIdWEWsLw9fFuXPJlGsE6dRhc4X9LvjdY4FbPo#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB08815> ;
    ns2:targetPopulation <http://purl.org/np/RAmiiMVoIdWEWsLw9fFuXPJlGsE6dRhc4X9LvjdY4FbPo#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAmiiMVoIdWEWsLw9fFuXPJlGsE6dRhc4X9LvjdY4FbPo#quote> ns1:value "Treatment of adult and adolescent patients (13 to 17 years) with schizophrenia" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afad3051-9df2-4c54-9684-e8262a133af8> .

<http://purl.org/np/RAmiiMVoIdWEWsLw9fFuXPJlGsE6dRhc4X9LvjdY4FbPo#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult and adolescent patients (13 to 17 years)" ;
    ns2:requiredMinAge "17" .

<http://purl.org/np/RAn7xU0UoT-4611w1HaqVGYw5RxWq157b4V2xCJus3yKo#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression)" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afad3051-9df2-4c54-9684-e8262a133af8> ],
        <http://purl.org/np/RAn7xU0UoT-4611w1HaqVGYw5RxWq157b4V2xCJus3yKo#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB08815> ;
    ns2:targetPopulation <http://purl.org/np/RAn7xU0UoT-4611w1HaqVGYw5RxWq157b4V2xCJus3yKo#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAn7xU0UoT-4611w1HaqVGYw5RxWq157b4V2xCJus3yKo#quote> ns1:value "Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression)" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afad3051-9df2-4c54-9684-e8262a133af8> .

<http://purl.org/np/RAn7xU0UoT-4611w1HaqVGYw5RxWq157b4V2xCJus3yKo#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_14042> ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAnLUKSpy5VDucMbVjgmMDX_H3Vtsu9qttypVQAZORHC4#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "For temporary relief of symptoms related to sleep disorders, Seasonal Affective Disorder, jet lag, and depression." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fdaf86c2-137d-4926-a63b-9faf7ec7e04c> ],
        <http://purl.org/np/RAnLUKSpy5VDucMbVjgmMDX_H3Vtsu9qttypVQAZORHC4#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01065> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAnLUKSpy5VDucMbVjgmMDX_H3Vtsu9qttypVQAZORHC4#quote> ns1:value "For temporary relief of symptoms related to sleep disorders, Seasonal Affective Disorder, jet lag, and depression." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fdaf86c2-137d-4926-a63b-9faf7ec7e04c> .

<http://purl.org/np/RAnOfzebuEnpwFdcU40FF-Uwb1QpIyqoK6KwxXiW5-OsM#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebe34db4-816d-4f0a-adbb-826693662754> ],
        <http://purl.org/np/RAnOfzebuEnpwFdcU40FF-Uwb1QpIyqoK6KwxXiW5-OsM#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00230> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAnOfzebuEnpwFdcU40FF-Uwb1QpIyqoK6KwxXiW5-OsM#quote> ns1:value "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebe34db4-816d-4f0a-adbb-826693662754> .

<http://purl.org/np/RAnPHasurBSXkBHn9Kwm6aDJyrgkekc5927fVTTzHZbe4#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Paroxetine tablets are indicated for the treatment of major depressive disorder." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> ],
        <http://purl.org/np/RAnPHasurBSXkBHn9Kwm6aDJyrgkekc5927fVTTzHZbe4#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00715> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAnPHasurBSXkBHn9Kwm6aDJyrgkekc5927fVTTzHZbe4#quote> ns1:value "Paroxetine tablets are indicated for the treatment of major depressive disorder." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> .

<http://purl.org/np/RAnhCeP3X1liJZQKE9wku7ENEAXNwHE_g_m3K4zNCiVH0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clobazam tablet is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=721dde68-db83-4dad-8649-8046cb455372> ],
        <http://purl.org/np/RAnhCeP3X1liJZQKE9wku7ENEAXNwHE_g_m3K4zNCiVH0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00349> ;
    ns2:targetPopulation <http://purl.org/np/RAnhCeP3X1liJZQKE9wku7ENEAXNwHE_g_m3K4zNCiVH0#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAnhCeP3X1liJZQKE9wku7ENEAXNwHE_g_m3K4zNCiVH0#quote> ns1:value "Clobazam tablet is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=721dde68-db83-4dad-8649-8046cb455372> .

<http://purl.org/np/RAnhCeP3X1liJZQKE9wku7ENEAXNwHE_g_m3K4zNCiVH0#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "patients 2 years of age or older" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_0050561> ;
    ns2:requiredMinAge "2" .

<http://purl.org/np/RAo05Sjr92Z_FWPob4xJKOG2_boxeXc1z40zem5pUjOkA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> ],
        <http://purl.org/np/RAo05Sjr92Z_FWPob4xJKOG2_boxeXc1z40zem5pUjOkA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01068> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAo05Sjr92Z_FWPob4xJKOG2_boxeXc1z40zem5pUjOkA#quote> ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> .

<http://purl.org/np/RAo1cJZBUOs9LhgAsqvTZWt02EL-mHxiYpEJaunijpQIA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Naltrexone hydrochloride tablets USP 50 mg is indicated in the treatment of alcohol dependence" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49aa3d6d-2270-4615-aafa-b440859ab870> ],
        <http://purl.org/np/RAo1cJZBUOs9LhgAsqvTZWt02EL-mHxiYpEJaunijpQIA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00704> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAo1cJZBUOs9LhgAsqvTZWt02EL-mHxiYpEJaunijpQIA#quote> ns1:value "Naltrexone hydrochloride tablets USP 50 mg is indicated in the treatment of alcohol dependence" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49aa3d6d-2270-4615-aafa-b440859ab870> .

<http://purl.org/np/RAo1dZTDE2eb359La5P9YIQiOo0TWZZM3eatB67_aOeYI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2503fff-c978-4efa-b1b4-d7740b6b26f2> ],
        <http://purl.org/np/RAo1dZTDE2eb359La5P9YIQiOo0TWZZM3eatB67_aOeYI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00669> ;
    ns2:targetPopulation <http://purl.org/np/RAo1dZTDE2eb359La5P9YIQiOo0TWZZM3eatB67_aOeYI#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAo1dZTDE2eb359La5P9YIQiOo0TWZZM3eatB67_aOeYI#quote> ns1:value "Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2503fff-c978-4efa-b1b4-d7740b6b26f2> .

<http://purl.org/np/RAo1dZTDE2eb359La5P9YIQiOo0TWZZM3eatB67_aOeYI#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAoJeKO0gIaK4qfQCq5zgXWqLYu3TStMAtY3f7cyn1BhU#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "If these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgment, felbamate oral suspension can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37> ],
        <http://purl.org/np/RAoJeKO0gIaK4qfQCq5zgXWqLYu3TStMAtY3f7cyn1BhU#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00949> ;
    ns2:targetPopulation <http://purl.org/np/RAoJeKO0gIaK4qfQCq5zgXWqLYu3TStMAtY3f7cyn1BhU#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAoJeKO0gIaK4qfQCq5zgXWqLYu3TStMAtY3f7cyn1BhU#quote> ns1:value "If these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgment, felbamate oral suspension can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37> .

<http://purl.org/np/RAoJeKO0gIaK4qfQCq5zgXWqLYu3TStMAtY3f7cyn1BhU#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "in children" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_0050561> ;
    ns2:requiredMaxAge "18" .

<http://purl.org/np/RAolwAqvqw_3V9EK_PSwyawD0eXPfkJ8XJOAHLkZmzDmM#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD)" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> ],
        <http://purl.org/np/RAolwAqvqw_3V9EK_PSwyawD0eXPfkJ8XJOAHLkZmzDmM#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00472> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAolwAqvqw_3V9EK_PSwyawD0eXPfkJ8XJOAHLkZmzDmM#quote> ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD)" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> .

<http://purl.org/np/RApLFKSXir-mwhWSl6FadOU9EcBCvvnhv5SYdmS2jespM#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> ],
        <http://purl.org/np/RApLFKSXir-mwhWSl6FadOU9EcBCvvnhv5SYdmS2jespM#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01068> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RApLFKSXir-mwhWSl6FadOU9EcBCvvnhv5SYdmS2jespM#quote> ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> .

<http://purl.org/np/RApYLfwfyTJ7lKQuesHrBh80zpkKyWpCrDc_plCVEwLW0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RApYLfwfyTJ7lKQuesHrBh80zpkKyWpCrDc_plCVEwLW0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RApYLfwfyTJ7lKQuesHrBh80zpkKyWpCrDc_plCVEwLW0#quote> ns1:value "In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RAppEliDizih-eOdMuanBbtpOVO5Mf7aZJVuvJvxi_5MM#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscoskeletal Pain" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea2dc1a6-22d5-4295-9d39-9bf015dc5a89> ],
        <http://purl.org/np/RAppEliDizih-eOdMuanBbtpOVO5Mf7aZJVuvJvxi_5MM#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00476> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAppEliDizih-eOdMuanBbtpOVO5Mf7aZJVuvJvxi_5MM#quote> ns1:value "Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscoskeletal Pain" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea2dc1a6-22d5-4295-9d39-9bf015dc5a89> .

<http://purl.org/np/RAq0pljKvE6O_AGxGHkh1SONBPo2AhQj4r40Qyi7nj3CA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f32a4532-7dfd-4aa5-bb48-afbbd2eefb7c> ],
        <http://purl.org/np/RAq0pljKvE6O_AGxGHkh1SONBPo2AhQj4r40Qyi7nj3CA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01156> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAq0pljKvE6O_AGxGHkh1SONBPo2AhQj4r40Qyi7nj3CA#quote> ns1:value "Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f32a4532-7dfd-4aa5-bb48-afbbd2eefb7c> .

<http://purl.org/np/RAq8zqvCqJSbrKJQ0_Lf75mRWyXzlHipV5vbSe6-cHZ_g#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Aripiprazole oral solution is indicated for the treatment of: Adjunctive Treatment of Major Depressive Disorder" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f272100-e02f-4a16-bb39-a2bf844db4f9> ],
        <http://purl.org/np/RAq8zqvCqJSbrKJQ0_Lf75mRWyXzlHipV5vbSe6-cHZ_g#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01238> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAq8zqvCqJSbrKJQ0_Lf75mRWyXzlHipV5vbSe6-cHZ_g#quote> ns1:value "Aripiprazole oral solution is indicated for the treatment of: Adjunctive Treatment of Major Depressive Disorder" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f272100-e02f-4a16-bb39-a2bf844db4f9> .

<http://purl.org/np/RAqc_p-BPO2VracLG3_X1LjJRHvWn1aXxHOFNfIfOwAkQ#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "RADICAVA is indicated for the treatment of amyotrophic lateral sclerosis (ALS)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11> ],
        <http://purl.org/np/RAqc_p-BPO2VracLG3_X1LjJRHvWn1aXxHOFNfIfOwAkQ#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB12243> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAqc_p-BPO2VracLG3_X1LjJRHvWn1aXxHOFNfIfOwAkQ#quote> ns1:value "RADICAVA is indicated for the treatment of amyotrophic lateral sclerosis (ALS)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11> .

<http://purl.org/np/RAr35wxXundGgR2ycR3eZnPmloYOQ1Ip3a6A3pgZbqiQ0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> ],
        <http://purl.org/np/RAr35wxXundGgR2ycR3eZnPmloYOQ1Ip3a6A3pgZbqiQ0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01068> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAr35wxXundGgR2ycR3eZnPmloYOQ1Ip3a6A3pgZbqiQ0#quote> ns1:value "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbce0e8-5098-4785-943b-8bdb5ff17fab> .

<http://purl.org/np/RAsiYjA9w_3VpllRg01zPjz5ljxelgy2BAVYt_iBqXd1s#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Frovatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94b996dc-ddc4-41ce-9a9f-3d91cb187473> ],
        <http://purl.org/np/RAsiYjA9w_3VpllRg01zPjz5ljxelgy2BAVYt_iBqXd1s#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00998> ;
    ns2:targetPopulation <http://purl.org/np/RAsiYjA9w_3VpllRg01zPjz5ljxelgy2BAVYt_iBqXd1s#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAsiYjA9w_3VpllRg01zPjz5ljxelgy2BAVYt_iBqXd1s#quote> ns1:value "Frovatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94b996dc-ddc4-41ce-9a9f-3d91cb187473> .

<http://purl.org/np/RAsiYjA9w_3VpllRg01zPjz5ljxelgy2BAVYt_iBqXd1s#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAsvNtNLN-qHRjBcnHd5FuIbL-7I-2um_Sy_pc2ffLBxo#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults with juvenile myoclonic epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> ],
        <http://purl.org/np/RAsvNtNLN-qHRjBcnHd5FuIbL-7I-2um_Sy_pc2ffLBxo#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01202> ;
    ns2:targetPopulation <http://purl.org/np/RAsvNtNLN-qHRjBcnHd5FuIbL-7I-2um_Sy_pc2ffLBxo#targetpop> ;
    ns3:indicationType ns3:AdjunctiveTherapy .

<http://purl.org/np/RAsvNtNLN-qHRjBcnHd5FuIbL-7I-2um_Sy_pc2ffLBxo#quote> ns1:value "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults with juvenile myoclonic epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9234b7-46b1-8e6c-a992-90f86cfb6e00> .

<http://purl.org/np/RAsvNtNLN-qHRjBcnHd5FuIbL-7I-2um_Sy_pc2ffLBxo#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult patients (16 years and older)" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/DOID_0111327> ;
    ns2:requiredMinAge "16" .

<http://purl.org/np/RAtBB7ydnmSMrgPcr5hd2Z_rwQ8EzJz3pHWfNEsnJ04nQ#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Aripiprazole oral solution is indicated for the treatment of: Schizophrenia" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f272100-e02f-4a16-bb39-a2bf844db4f9> ],
        <http://purl.org/np/RAtBB7ydnmSMrgPcr5hd2Z_rwQ8EzJz3pHWfNEsnJ04nQ#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01238> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAtBB7ydnmSMrgPcr5hd2Z_rwQ8EzJz3pHWfNEsnJ04nQ#quote> ns1:value "Aripiprazole oral solution is indicated for the treatment of: Schizophrenia" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f272100-e02f-4a16-bb39-a2bf844db4f9> .

<http://purl.org/np/RAtsJmmAQaWwBE34o5qsvLBIUn38IgFgry4Ua7sW31a3k#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Baclofen may also be of some value in patients with spinal cord injuries and other spinal cord diseases." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=346af8fe-3816-49de-bfd3-5a7425e728f9> ],
        <http://purl.org/np/RAtsJmmAQaWwBE34o5qsvLBIUn38IgFgry4Ua7sW31a3k#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00181> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAtsJmmAQaWwBE34o5qsvLBIUn38IgFgry4Ua7sW31a3k#quote> ns1:value "Baclofen may also be of some value in patients with spinal cord injuries and other spinal cord diseases." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=346af8fe-3816-49de-bfd3-5a7425e728f9> .

<http://purl.org/np/RAtumd4K7npN3hNOca-3BbxKHlEPACxGb_r44u0Oplw8U#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "USES: For the temporary relief of discomfort and pain associated with - minor burns and skin irritations, minor cuts and scrapes, itching. Adults and children 12 years of age and older: Apply to affected area not more than 3-4 times daily." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60cafbaf-8ec6-46a5-e053-2a91aa0af11f> ],
        <http://purl.org/np/RAtumd4K7npN3hNOca-3BbxKHlEPACxGb_r44u0Oplw8U#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01086> ;
    ns2:targetPopulation <http://purl.org/np/RAtumd4K7npN3hNOca-3BbxKHlEPACxGb_r44u0Oplw8U#targetpop> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAtumd4K7npN3hNOca-3BbxKHlEPACxGb_r44u0Oplw8U#quote> ns1:value "USES: For the temporary relief of discomfort and pain associated with - minor burns and skin irritations, minor cuts and scrapes, itching. Adults and children 12 years of age and older: Apply to affected area not more than 3-4 times daily." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60cafbaf-8ec6-46a5-e053-2a91aa0af11f> .

<http://purl.org/np/RAtumd4K7npN3hNOca-3BbxKHlEPACxGb_r44u0Oplw8U#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "Adults and children 12 years of age and older" ;
    ns2:healthCondition <http://purl.obolibrary.org/obo/SYMP_0000099> ;
    ns2:requiredMinAge "12" .

<http://purl.org/np/RAuLe5lHz_Om5DowNM9XR0bIHY381O73q-gBCKl2V_vCY#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7e467c02-49a0-4b62-b537-430fdfa4f10e> ],
        <http://purl.org/np/RAuLe5lHz_Om5DowNM9XR0bIHY381O73q-gBCKl2V_vCY#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00252> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAuLe5lHz_Om5DowNM9XR0bIHY381O73q-gBCKl2V_vCY#quote> ns1:value "Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7e467c02-49a0-4b62-b537-430fdfa4f10e> .

<http://purl.org/np/RAudTjRmo213Dadt2UiHwtNCDDkMG9LfrW533mQMpeMwg#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Lithium Carbonate Extended-Release Tablets USP are indicated in the treatment of manic episodes of Bipolar Disorder." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebda1da0-38a2-49a0-8478-5d1d991a63bd> ],
        <http://purl.org/np/RAudTjRmo213Dadt2UiHwtNCDDkMG9LfrW533mQMpeMwg#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB14509> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAudTjRmo213Dadt2UiHwtNCDDkMG9LfrW533mQMpeMwg#quote> ns1:value "Lithium Carbonate Extended-Release Tablets USP are indicated in the treatment of manic episodes of Bipolar Disorder." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebda1da0-38a2-49a0-8478-5d1d991a63bd> .

<http://purl.org/np/RAv-n0KEBxf2JyY8cDdAfhtDBwjtP8Np9b-yn-BHZl0Qg#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Memantine hydrochloride oral solution is indicated for the treatment of moderate to severe dementia of the Alzheimer's type." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4076d3ef-d0a9-96c5-1a15-812c1e42929c> ],
        <http://purl.org/np/RAv-n0KEBxf2JyY8cDdAfhtDBwjtP8Np9b-yn-BHZl0Qg#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01043> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAv-n0KEBxf2JyY8cDdAfhtDBwjtP8Np9b-yn-BHZl0Qg#quote> ns1:value "Memantine hydrochloride oral solution is indicated for the treatment of moderate to severe dementia of the Alzheimer's type." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4076d3ef-d0a9-96c5-1a15-812c1e42929c> .

<http://purl.org/np/RAv3jvyRhHFwJRpDqoVUn5fgjWTJWcU26JmNFRvmpyMv0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Riluzole is indicated for the treatment of amyotrophic lateral sclerosis(ALS)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd432c13-389e-46b3-8891-0cf1a58800ff> ],
        <http://purl.org/np/RAv3jvyRhHFwJRpDqoVUn5fgjWTJWcU26JmNFRvmpyMv0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00740> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAv3jvyRhHFwJRpDqoVUn5fgjWTJWcU26JmNFRvmpyMv0#quote> ns1:value "Riluzole is indicated for the treatment of amyotrophic lateral sclerosis(ALS)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd432c13-389e-46b3-8891-0cf1a58800ff> .

<http://purl.org/np/RAvJsGhV9iHDO9ROYo6u505WGpdFdhf9KN_D0Y615QLFA#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94e984da-3b08-406f-8c10-e78844fca1ff> ],
        <http://purl.org/np/RAvJsGhV9iHDO9ROYo6u505WGpdFdhf9KN_D0Y615QLFA#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00321> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAvJsGhV9iHDO9ROYo6u505WGpdFdhf9KN_D0Y615QLFA#quote> ns1:value "For the relief of symptoms of depression. Endogenous depression is more likely to be alleviated than other depressive states" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94e984da-3b08-406f-8c10-e78844fca1ff> .

<http://purl.org/np/RAvluTH6ahxoy0XuwfVTy3pGDitosYWrmTMinhzrRR1ro#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Iloperidone tablets are indicated for the treatment of schizophrenia in adults." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eeb0fcfd-e4e8-4fb1-9635-901dc9446235> ],
        <http://purl.org/np/RAvluTH6ahxoy0XuwfVTy3pGDitosYWrmTMinhzrRR1ro#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB04946> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAvluTH6ahxoy0XuwfVTy3pGDitosYWrmTMinhzrRR1ro#quote> ns1:value "Iloperidone tablets are indicated for the treatment of schizophrenia in adults." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eeb0fcfd-e4e8-4fb1-9635-901dc9446235> .

<http://purl.org/np/RAvxGuz3o7uA48O-l5wUUrm_CEuuO9uG_YF3vI6O0918o#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Paroxetine tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) as defined in the DSM-IV." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> ],
        <http://purl.org/np/RAvxGuz3o7uA48O-l5wUUrm_CEuuO9uG_YF3vI6O0918o#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00715> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAvxGuz3o7uA48O-l5wUUrm_CEuuO9uG_YF3vI6O0918o#quote> ns1:value "Paroxetine tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) as defined in the DSM-IV." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dd7e24-85fc-4152-89ea-47ec2b48a1ed> .

<http://purl.org/np/RAwa1r-Auffn2MDHyFUfKBQKuiSqZK5S65IFdeLtDql1s#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Pramipexole dihydrochloride tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS)." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4fe7106d-4bf6-4794-87cb-8df616994c41> ],
        <http://purl.org/np/RAwa1r-Auffn2MDHyFUfKBQKuiSqZK5S65IFdeLtDql1s#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00413> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAwa1r-Auffn2MDHyFUfKBQKuiSqZK5S65IFdeLtDql1s#quote> ns1:value "Pramipexole dihydrochloride tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS)." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4fe7106d-4bf6-4794-87cb-8df616994c41> .

<http://purl.org/np/RAwn8YnBwDaBhsX6nZOMwLOtIwVnnPdX9hkUwRuZoe4-Q#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Thiothixene capsules are effective in the management of schizophrenia." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13d90931-e9d8-25f3-a045-608d0404cd7a> ],
        <http://purl.org/np/RAwn8YnBwDaBhsX6nZOMwLOtIwVnnPdX9hkUwRuZoe4-Q#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01623> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAwn8YnBwDaBhsX6nZOMwLOtIwVnnPdX9hkUwRuZoe4-Q#quote> ns1:value "Thiothixene capsules are effective in the management of schizophrenia." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13d90931-e9d8-25f3-a045-608d0404cd7a> .

<http://purl.org/np/RAy8JkAfLP8_aPC6Wcc88bXlgrtQVStjUCFNXfivcwadI#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Diazepam is indicated for the management of anxiety disorders for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> ],
        <http://purl.org/np/RAy8JkAfLP8_aPC6Wcc88bXlgrtQVStjUCFNXfivcwadI#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00829> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAy8JkAfLP8_aPC6Wcc88bXlgrtQVStjUCFNXfivcwadI#quote> ns1:value "Diazepam is indicated for the management of anxiety disorders for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa352464-14c8-49e9-b8b7-5a968b1cfa93> .

<http://purl.org/np/RAy8bkI3AcqM8QmbzD6cliOUcQdGruCIpPKak4v9NdVx0#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of Major Depressive Disorder in adult patients and in pediatric patients aged 8 to18 years" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> ],
        <http://purl.org/np/RAy8bkI3AcqM8QmbzD6cliOUcQdGruCIpPKak4v9NdVx0#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00472> ;
    ns2:targetPopulation <http://purl.org/np/RAy8bkI3AcqM8QmbzD6cliOUcQdGruCIpPKak4v9NdVx0#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAy8bkI3AcqM8QmbzD6cliOUcQdGruCIpPKak4v9NdVx0#quote> ns1:value "Fluoxetine is indicated for the acute and maintenance treatment of Major Depressive Disorder in adult patients and in pediatric patients aged 8 to18 years" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439> .

<http://purl.org/np/RAy8bkI3AcqM8QmbzD6cliOUcQdGruCIpPKak4v9NdVx0#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adult and pediatric patients" ;
    ns2:requiredMinAge "8" .

<http://purl.org/np/RAyDzLntiVLeZa2RNoi55Ow6ojE8RDb_3ngKDimXFicr8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Marplan is indicated for the treatment of depression. Because of its potentially serious side effects, Marplan is not an antidepressant of first choice in the treatment of newly diagnosed depressed patient" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac387aa0-3f04-4865-a913-db6ed6f4fdc5> ],
        <http://purl.org/np/RAyDzLntiVLeZa2RNoi55Ow6ojE8RDb_3ngKDimXFicr8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01247> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAyDzLntiVLeZa2RNoi55Ow6ojE8RDb_3ngKDimXFicr8#quote> ns1:value "Marplan is indicated for the treatment of depression. Because of its potentially serious side effects, Marplan is not an antidepressant of first choice in the treatment of newly diagnosed depressed patient" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac387aa0-3f04-4865-a913-db6ed6f4fdc5> .

<http://purl.org/np/RAyNDQWKL9XEsT0IiU9fyuO_m_4IOQdS41Sz-G75vipT8#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "temporarily relieves minor aches and pains due to:•the common cold•headache•backache•minor pain of arthritis•toothache•muscular aches•premenstrual and menstrual cramps•temporarily reduces fever" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f7cca9d-4230-49d7-b805-a1fbc73e31c9> ],
        <http://purl.org/np/RAyNDQWKL9XEsT0IiU9fyuO_m_4IOQdS41Sz-G75vipT8#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00316> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAyNDQWKL9XEsT0IiU9fyuO_m_4IOQdS41Sz-G75vipT8#quote> ns1:value "temporarily relieves minor aches and pains due to:•the common cold•headache•backache•minor pain of arthritis•toothache•muscular aches•premenstrual and menstrual cramps•temporarily reduces fever" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f7cca9d-4230-49d7-b805-a1fbc73e31c9> .

<http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Felbamate oral suspension is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use" ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37> ],
        <http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB00949> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#quote> ns1:value "Felbamate oral suspension is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use" ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37> .

<http://purl.org/np/RAyveo6zcLmZSFEGoyAeMma-904_aPF_v143JhtP_SC7s#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Sertraline tablets are indicated for the treatment of social anxiety disorder, also known as social phobia in adults." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> ],
        <http://purl.org/np/RAyveo6zcLmZSFEGoyAeMma-904_aPF_v143JhtP_SC7s#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB08567> ;
    ns2:targetPopulation <http://purl.org/np/RAyveo6zcLmZSFEGoyAeMma-904_aPF_v143JhtP_SC7s#targetpop> ;
    ns3:indicationType ns2:TreatmentIndication .

<http://purl.org/np/RAyveo6zcLmZSFEGoyAeMma-904_aPF_v143JhtP_SC7s#quote> ns1:value "Sertraline tablets are indicated for the treatment of social anxiety disorder, also known as social phobia in adults." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9641190-9151-4f7e-89ff-1e7a818c30ee> .

<http://purl.org/np/RAyveo6zcLmZSFEGoyAeMma-904_aPF_v143JhtP_SC7s#targetpop> a ns2:PeopleAudience ;
    ns2:audienceType "adults" ;
    ns2:requiredMinAge "18" .

<http://purl.org/np/RAzO-241bI4XZrmYTOwWGx8o3Cs0ClqBNZk6aD8eUcFRY#medtherapy> a ns2:MedicalTherapy ;
    ns1:wasDerivedFrom [ ns1:value "Fosphenytoin sodium injection is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery." ;
            ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> ],
        <http://purl.org/np/RAzO-241bI4XZrmYTOwWGx8o3Cs0ClqBNZk6aD8eUcFRY#quote> ;
    ns2:drug <http://identifiers.org/drugbank/DB01320> ;
    ns3:indicationType ns3:SymptomaticReliefIndication .

<http://purl.org/np/RAzO-241bI4XZrmYTOwWGx8o3Cs0ClqBNZk6aD8eUcFRY#quote> ns1:value "Fosphenytoin sodium injection is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery." ;
    ns1:wasQuotedFrom <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> .

<http://sbmi.uth.tmc.edu/ontology/ochv#C0718667> a ns2:MedicalCondition .

<https://identifiers.org/HP:0000737> a ns2:MedicalCondition .

<https://identifiers.org/HP:0002013> a ns2:MedicalCondition .

<https://identifiers.org/HP:0032661> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0002009> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0002406> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0005115> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0005263> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0005582> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0005754> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0015137> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0016532> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0020074> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0021146> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0021668> a ns2:MedicalCondition .

<http://identifiers.org/drugbank/DB00181> a ns2:Drug .

<http://identifiers.org/drugbank/DB00182> a ns2:Drug .

<http://identifiers.org/drugbank/DB00252> a ns2:Drug .

<http://identifiers.org/drugbank/DB00268> a ns2:Drug .

<http://identifiers.org/drugbank/DB00295> a ns2:Drug .

<http://identifiers.org/drugbank/DB00316> a ns2:Drug .

<http://identifiers.org/drugbank/DB00321> a ns2:Drug .

<http://identifiers.org/drugbank/DB00344> a ns2:Drug .

<http://identifiers.org/drugbank/DB00349> a ns2:Drug .

<http://identifiers.org/drugbank/DB00376> a ns2:Drug .

<http://identifiers.org/drugbank/DB00413> a ns2:Drug .

<http://identifiers.org/drugbank/DB01080> a ns2:Drug .

<http://identifiers.org/drugbank/DB01156> a ns2:Drug .

<http://identifiers.org/drugbank/DB01175> a ns2:Drug .

<http://identifiers.org/drugbank/DB01320> a ns2:Drug .

<http://identifiers.org/drugbank/DB01576> a ns2:Drug .

<http://identifiers.org/drugbank/DB05316> a ns2:Drug .

<http://purl.bioontology.org/ontology/MEDDRA/10012402> a ns2:MedicalCondition .

<https://identifiers.org/HP:0025190> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0005027> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0005384> a ns2:MedicalCondition .

<https://identifiers.org/MONDO:0024612> a ns2:MedicalCondition .

<http://identifiers.org/drugbank/DB00780> a ns2:Drug .

<http://identifiers.org/drugbank/DB00949> a ns2:Drug .

<http://identifiers.org/drugbank/DB01065> a ns2:Drug .

<http://identifiers.org/drugbank/DB01202> a ns2:Drug .

<http://identifiers.org/drugbank/DB01224> a ns2:Drug .

<http://identifiers.org/drugbank/DB08815> a ns2:Drug .

<http://purl.obolibrary.org/obo/DOID_0050561> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA-SgNkbxNaUjzG2urhUzqWT0slTx7mGl1mV4qaS3cVeg#medtherapy>,
        <http://purl.org/np/RA27c2O-kozxjC5IefxMGSneu-bQmje9BqVj8pYVI1uVk#medtherapy>,
        <http://purl.org/np/RACwmZC5WsfNbesSttEo1SI2ZR8uWA412-VbtAIVQ8wJI#medtherapy>,
        <http://purl.org/np/RATxISZAhIHtOdOcObiF3psNaG4KvkUOpWgAhAMtY7VeU#medtherapy>,
        <http://purl.org/np/RAnhCeP3X1liJZQKE9wku7ENEAXNwHE_g_m3K4zNCiVH0#medtherapy>,
        <http://purl.org/np/RAo05Sjr92Z_FWPob4xJKOG2_boxeXc1z40zem5pUjOkA#medtherapy>,
        <http://purl.org/np/RAoJeKO0gIaK4qfQCq5zgXWqLYu3TStMAtY3f7cyn1BhU#medtherapy>,
        <http://purl.org/np/RApLFKSXir-mwhWSl6FadOU9EcBCvvnhv5SYdmS2jespM#medtherapy> ;
    ns2:signOrSymptom <https://identifiers.org/MONDO:0005027>,
        <https://identifiers.org/MONDO:0005384> .

<http://purl.obolibrary.org/obo/DOID_14042> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA1DXMXWhyK3Na8qZ1Iujyt6C2VGubEQIfF-22WsrCwXM#medtherapy>,
        <http://purl.org/np/RA2dQdtUAn_I3jvaTARl3nKZEstqyINdsDa0rCa2Oxyec#medtherapy>,
        <http://purl.org/np/RA4RQidK46yolCNNlZoDetKG69PuKVS91_RIlGlUx3jgk#medtherapy>,
        <http://purl.org/np/RAB8au2sKSsDGwwtswkhDSAXbiDF97-t4CXDDxbFw3DX0#medtherapy>,
        <http://purl.org/np/RAGN7ijOmDfmPgBu7OHccNwALSaa_a8iulT6KR1VIh8F8#medtherapy>,
        <http://purl.org/np/RAGr5IIjcYVTGqbOorqy5jy1Xqh1CTwdlCnnSmjUMfGUE#medtherapy>,
        <http://purl.org/np/RAVEw_yFWhB_mycDe0UNnldtUAVssPKoJ15i7dHWoJMa0#medtherapy>,
        <http://purl.org/np/RAXC5X6BalHUIKv3Mu8MDuqaa_Ctr2rya5Lcm3U0DwxVI#medtherapy>,
        <http://purl.org/np/RAZD0J6i7HXVATsy1HYgDs3QlLICLxUAA2j2wffAphNv8#medtherapy>,
        <http://purl.org/np/RAg86crtDEhv7zKWrf8yRC4c8tkSn1J1XLQ8SsgObH3_o#medtherapy>,
        <http://purl.org/np/RAj8XJBzGFMRz7oBD98LvUd7lXD2_nEGhaXcKr1Fdckxs#medtherapy>,
        <http://purl.org/np/RAn7xU0UoT-4611w1HaqVGYw5RxWq157b4V2xCJus3yKo#medtherapy> ;
    ns2:signOrSymptom <http://purl.bioontology.org/ontology/MEDDRA/10012402>,
        <http://purl.bioontology.org/ontology/MEDDRA/10026778>,
        <http://purl.obolibrary.org/obo/MFOMD_0000145>,
        <http://purl.obolibrary.org/obo/MFOMD_0000149>,
        <https://identifiers.org/MONDO:0002009>,
        <https://identifiers.org/MONDO:0005263>,
        <https://identifiers.org/MONDO:0024612> .

<http://identifiers.org/drugbank/DB00230> a ns2:Drug .

<http://identifiers.org/drugbank/DB00273> a ns2:Drug .

<http://identifiers.org/drugbank/DB00476> a ns2:Drug .

<http://identifiers.org/drugbank/DB01238> a ns2:Drug .

<http://purl.obolibrary.org/obo/DOID_1826> a ns2:MedicalCondition ;
    ns2:possibleTreatment <http://purl.org/np/RA83ToxRvM673udY2pWq9hw_0ctIY-kZX9LL5IhMDr73o#medtherapy>,
        <http://purl.org/np/RAKcLCXliAoGMctRyClbxGwKs-qtqDJHN916bxoXuhhVg#medtherapy>,
        <http://purl.org/np/RAOxMuO5TN2MfPl8sTi9Flns8Hpfiak7nnW2tEAWrF1GM#medtherapy>,
        <http://purl.org/np/RAXv-RjzkkyXPSfQVP06bHElhavrn8HJsiQPYmjNQddjA#medtherapy>,
        <http://purl.org/np/RAbzl9aPdve5RHvCzOfardZ8LdZU2I2iIqYBCJg9c7Gpc#medtherapy>,
        <http://purl.org/np/RAdd2yLrhTMtrGoDA1ZVLZaThCJ4WYi5oQhAcC0hmjkn8#medtherapy>,
        <http://purl.org/np/RAuLe5lHz_Om5DowNM9XR0bIHY381O73q-gBCKl2V_vCY#medtherapy>,
        <http://purl.org/np/RAySK-31NxhJAtKuFF_ytCHfpLYrFRXPWh6IRW_TwfwBY#medtherapy>,
        <http://purl.org/np/RAzO-241bI4XZrmYTOwWGx8o3Cs0ClqBNZk6aD8eUcFRY#medtherapy> ;
    ns2:signOrSymptom <http://purl.bioontology.org/ontology/MEDDRA/10037214>,
        <https://identifiers.org/HP:0025190>,
        <https://identifiers.org/HP:0032661>,
        <https://identifiers.org/MONDO:0005027>,
        <https://identifiers.org/MONDO:0005115>,
        <https://identifiers.org/MONDO:0005384>,
        <https://identifiers.org/MONDO:0005754>,
        <https://identifiers.org/MONDO:0016532> .

<http://identifiers.org/drugbank/DB00734> a ns2:Drug .

<http://identifiers.org/drugbank/DB00715> a ns2:Drug .

<http://identifiers.org/drugbank/DB08567> a ns2:Drug .

<http://identifiers.org/drugbank/DB00472> a ns2:Drug .

<http://identifiers.org/drugbank/DB01068> a ns2:Drug .

<http://identifiers.org/drugbank/DB00555> a ns2:Drug .

<http://identifiers.org/drugbank/DB00829> a ns2:Drug .

